{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 36, "items": [{"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T18:35:40Z", "timestamp": 1575138940453}, "reference-count": 0, "publisher": "Alphamed Press", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Oncologist"], "published-print": {"date-parts": [[2005, 3, 1]]}, "DOI": "10.1634/theoncologist.10-3-176", "type": "journal-article", "created": {"date-parts": [[2005, 3, 25]], "date-time": "2005-03-25T19:52:49Z", "timestamp": 1111780369000}, "page": "176-182", "source": "Crossref", "is-referenced-by-count": 227, "title": ["FDA Drug Approval Summary: Azacitidine (5-azacytidine, VidazaTM) for Injectable Suspension"], "prefix": "10.1634", "volume": "10", "author": [{"given": "E.", "family": "Kaminskas", "sequence": "first", "affiliation": []}], "member": "638", "container-title": ["The Oncologist"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1634/theoncologist.10-3-176", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T00:17:45Z", "timestamp": 1482452265000}, "score": 90.92314, "issued": {"date-parts": [[2005, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 3, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1634/theoncologist.10-3-176", "ISSN": ["1083-7159", "1549-490X"], "issn-type": [{"value": "1083-7159", "type": "print"}, {"value": "1549-490X", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:10:19Z", "timestamp": 1575177019471}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2005, 5, 15]]}, "DOI": "10.1158/1078-0432.ccr-04-2135", "type": "journal-article", "created": {"date-parts": [[2005, 9, 21]], "date-time": "2005-09-21T23:46:37Z", "timestamp": 1127346397000}, "page": "3604-3608", "source": "Crossref", "is-referenced-by-count": 239, "title": ["Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes"], "prefix": "10.1158", "volume": "11", "author": [{"given": "E.", "family": "Kaminskas", "sequence": "first", "affiliation": []}], "member": "1086", "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-04-2135", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T03:45:19Z", "timestamp": 1482464719000}, "score": 46.186977, "issued": {"date-parts": [[2005, 5, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 5, 15]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-04-2135", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T15:00:56Z", "timestamp": 1574866856920}, "reference-count": 0, "publisher": "Alphamed Press", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Oncologist"], "published-print": {"date-parts": [[2018, 12]]}, "DOI": "10.1634/theoncologist.2018-0295", "type": "journal-article", "created": {"date-parts": [[2018, 8, 17]], "date-time": "2018-08-17T15:57:24Z", "timestamp": 1534521444000}, "page": "1520-1524", "source": "Crossref", "is-referenced-by-count": 4, "title": ["FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim\u2010Chester Disease with the BRAFV600 Mutation"], "prefix": "10.1634", "volume": "23", "author": [{"given": "Patricia A.", "family": "Oneal", "sequence": "first", "affiliation": []}, {"given": "Virginia", "family": "Kwitkowski", "sequence": "additional", "affiliation": []}, {"given": "Lola", "family": "Luo", "sequence": "additional", "affiliation": []}, {"given": "Yuan Li", "family": "Shen", "sequence": "additional", "affiliation": []}, {"given": "Sriram", "family": "Subramaniam", "sequence": "additional", "affiliation": []}, {"given": "Stacy", "family": "Shord", "sequence": "additional", "affiliation": []}, {"given": "Kirsten B.", "family": "Goldberg", "sequence": "additional", "affiliation": []}, {"given": "Amy E.", "family": "McKee", "sequence": "additional", "affiliation": []}, {"given": "Edvardas", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "Ann", "family": "Farrell", "sequence": "additional", "affiliation": []}, {"given": "Richard", "family": "Pazdur", "sequence": "additional", "affiliation": []}], "member": "638", "published-online": {"date-parts": [[2018, 8, 17]]}, "container-title": ["The Oncologist"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1634/theoncologist.2018-0295", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 12, 21]], "date-time": "2018-12-21T21:55:38Z", "timestamp": 1545429338000}, "score": 30.212633, "issued": {"date-parts": [[2018, 8, 17]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2018, 12, 13]]}, "published-print": {"date-parts": [[2018, 12]]}, "issue": "12"}, "alternative-id": ["10.1634/theoncologist.2018-0295"], "URL": "http://dx.doi.org/10.1634/theoncologist.2018-0295", "ISSN": ["1083-7159", "1549-490X"], "issn-type": [{"value": "1083-7159", "type": "print"}, {"value": "1549-490X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:47:10Z", "timestamp": 1574754430770}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "22", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "short-container-title": ["Clin Cancer Res"], "published-print": {"date-parts": [[2017, 11, 15]]}, "DOI": "10.1158/1078-0432.ccr-16-2870", "type": "journal-article", "created": {"date-parts": [[2017, 3, 2]], "date-time": "2017-03-02T01:55:19Z", "timestamp": 1488419719000}, "page": "6759-6763", "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 6, "title": ["FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma"], "prefix": "10.1158", "volume": "23", "author": [{"given": "Nicole J.", "family": "Gormley", "sequence": "first", "affiliation": []}, {"given": "Chia-Wen", "family": "Ko", "sequence": "additional", "affiliation": []}, {"given": "Albert", "family": "Deisseroth", "sequence": "additional", "affiliation": []}, {"given": "Lei", "family": "Nie", "sequence": "additional", "affiliation": []}, {"given": "Edvardas", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "Natasha", "family": "Kormanik", "sequence": "additional", "affiliation": []}, {"given": "Kirsten B.", "family": "Goldberg", "sequence": "additional", "affiliation": []}, {"given": "Ann T.", "family": "Farrell", "sequence": "additional", "affiliation": []}, {"given": "Richard", "family": "Pazdur", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2017, 3, 1]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-16-2870", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 15]], "date-time": "2017-11-15T05:46:18Z", "timestamp": 1510724778000}, "score": 29.016907, "issued": {"date-parts": [[2017, 3, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2017, 11, 14]]}, "published-print": {"date-parts": [[2017, 11, 15]]}, "issue": "22"}, "alternative-id": ["10.1158/1078-0432.CCR-16-2870"], "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-16-2870", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T18:09:03Z", "timestamp": 1574791743114}, "reference-count": 68, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 7, 1]], "date-time": "2016-07-01T00:00:00Z", "timestamp": 1467331200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "ahjonline.com", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["American Heart Journal"], "published-print": {"date-parts": [[2016, 7]]}, "DOI": "10.1016/j.ahj.2016.04.010", "type": "journal-article", "created": {"date-parts": [[2016, 5, 1]], "date-time": "2016-05-01T05:47:44Z", "timestamp": 1462081664000}, "page": "74-86", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 18, "title": ["NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank"], "prefix": "10.1016", "volume": "177", "author": [{"given": "James A.", "family": "Reiffel", "sequence": "first", "affiliation": []}, {"given": "Jeffrey I.", "family": "Weitz", "sequence": "additional", "affiliation": []}, {"given": "Paul", "family": "Reilly", "sequence": "additional", "affiliation": []}, {"given": "Edvardas", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "Troy", "family": "Sarich", "sequence": "additional", "affiliation": []}, {"given": "Philip", "family": "Sager", "sequence": "additional", "affiliation": []}, {"given": "Jonathan", "family": "Seltzer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["American Heart Journal"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0002870316300308?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0002870316300308?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 7]], "date-time": "2019-09-07T06:20:16Z", "timestamp": 1567837216000}, "score": 24.559418, "issued": {"date-parts": [[2016, 7]]}, "references-count": 68, "alternative-id": ["S0002870316300308"], "URL": "http://dx.doi.org/10.1016/j.ahj.2016.04.010", "ISSN": ["0002-8703"], "issn-type": [{"value": "0002-8703", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank", "name": "articletitle", "label": "Article Title"}, {"value": "American Heart Journal", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ahj.2016.04.010", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T20:06:44Z", "timestamp": 1575403604376}, "reference-count": 94, "publisher": "Informa UK Limited", "issue": "6", "funder": [{"DOI": "10.13039/501100001794", "name": "University of Queensland", "doi-asserted-by": "crossref", "award": []}], "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Drug Development and Industrial Pharmacy"], "published-print": {"date-parts": [[2019, 6, 3]]}, "DOI": "10.1080/03639045.2019.1583758", "type": "journal-article", "created": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T12:07:55Z", "timestamp": 1550232475000}, "page": "882-894", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?"], "prefix": "10.1080", "volume": "45", "author": [{"given": "Nirmal", "family": "Marasini", "sequence": "first", "affiliation": [{"name": "School of Biomedical Sciences, Faculty of medicine, The University of Queensland, St Lucia, Australia"}]}, {"given": "Lisa M.", "family": "Kaminskas", "sequence": "additional", "affiliation": [{"name": "School of Biomedical Sciences, Faculty of medicine, The University of Queensland, St Lucia, Australia"}]}], "member": "301", "published-online": {"date-parts": [[2019, 3]]}, "reference": [{"key": "CIT0002", "DOI": "10.2165/11206860-000000000-00000", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1073/pnas.1402981111", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1503/cmaj.101720", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1016/j.vaccine.2017.02.005", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1586/14760584.2014.936852", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1016/j.addr.2005.12.003", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1038/nri2236", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1038/nri3251", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1146/annurev-immunol-031210-101317", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1128/CVI.00590-15", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1038/mi.2013.120", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1016/j.cocis.2017.06.003", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1016/j.coviro.2012.03.009", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1186/1465-9921-7-29", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "author": "Reed KD", "first-page": "1499", "year": "2015", "volume-title": "Molecular medical microbiology"}, {"key": "CIT0017", "DOI": "10.1371/journal.ppat.1003057", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1111/j.0105-2896.2005.00299.x", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.4049/jimmunol.168.4.1796", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1128/JVI.74.8.3455-3463.2000", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.4049/jimmunol.167.6.3293", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.4049/jimmunol.0903794", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1016/B978-0-323-39981-4.00019-1", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.4155/tde-2016-0068", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.3389/fimmu.2017.00359", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.4049/jimmunol.172.10.6259", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.7774/cevr.2013.2.2.128", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.3389/fimmu.2018.00320", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.1073/pnas.1620194114", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "DOI": "10.1513/pats.200508-090JS", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "DOI": "10.1016/j.biocel.2008.01.003", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "author": "Tomioka H", "first-page": "635451", "year": "2012", "journal-title": "Clin Dev Immunol"}, {"key": "CIT0033", "DOI": "10.21769/BioProtoc.2182", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "DOI": "10.4049/jimmunol.0901089", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1007/s12026-012-8359-6", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.4049/jimmunol.175.3.1609", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.5339/gcsp.2015.2", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "DOI": "10.1165/rcmb.2012-0387OC", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.4049/jimmunol.1203131", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1080/21645515.2016.1259042", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.2147/MDER.S125104", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.1016/j.vaccine.2007.10.035", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1586/erv.12.101", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1080/21645515.2017.1356952", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "DOI": "10.1089/jamp.2014.1176", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "DOI": "10.4161/hv.27332", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.3390/vaccines3020320", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "DOI": "10.4110/in.2015.15.2.51", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "author": "Mohan T", "volume": "138", "first-page": "779", "year": "2013", "journal-title": "Indian J Med Res"}, {"key": "CIT0050", "DOI": "10.1371/journal.pone.0006999", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "DOI": "10.1080/21645515.2016.1181236", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "DOI": "10.3390/toxins9120379", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "author": "Ahmed T", "volume": "5", "first-page": "Cd009029", "year": "2013", "journal-title": "Cochrane Database Syst Rev"}, {"key": "CIT0054", "author": "Bergquist C", "volume": "65", "first-page": "2676", "year": "1997", "journal-title": "Infect Immun"}, {"key": "CIT0055", "DOI": "10.1177/2051013617691041", "doi-asserted-by": "publisher"}, {"key": "CIT0056", "DOI": "10.1016/B978-0-323-39981-4.00012-9", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "DOI": "10.1159/000445116", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1016/j.nano.2016.03.002", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1586/erv.11.15", "doi-asserted-by": "publisher"}, {"key": "CIT0060", "DOI": "10.1371/journal.pone.0061287", "doi-asserted-by": "publisher"}, {"key": "CIT0061", "DOI": "10.1128/JVI.02018-15", "doi-asserted-by": "publisher"}, {"key": "CIT0062", "DOI": "10.2217/nnm-2017-0254", "doi-asserted-by": "publisher"}, {"key": "CIT0063", "DOI": "10.1016/j.celrep.2015.04.009", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "DOI": "10.1038/nbt1332", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "DOI": "10.1021/acsnano.6b07343", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "DOI": "10.1007/s11095-015-1806-z", "doi-asserted-by": "publisher"}, {"key": "CIT0067", "DOI": "10.2174/1573406412666160720093138", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "DOI": "10.1111/j.1365-2567.2012.03558.x", "doi-asserted-by": "publisher"}, {"key": "CIT0069", "DOI": "10.1007/s11095-010-0094-x", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "DOI": "10.1016/j.ymeth.2006.05.016", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "DOI": "10.1517/17425247.2016.1121989", "doi-asserted-by": "publisher"}, {"key": "CIT0072", "DOI": "10.1371/journal.pone.0139785", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "DOI": "10.1586/erv.11.17", "doi-asserted-by": "publisher"}, {"key": "CIT0074", "DOI": "10.1016/j.intimp.2018.06.027", "doi-asserted-by": "publisher"}, {"key": "CIT0075", "DOI": "10.1016/j.actbio.2016.04.012", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.2174/1567201813666160721141322", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "DOI": "10.2217/nnm-2016-0291", "doi-asserted-by": "publisher"}, {"key": "CIT0078", "DOI": "10.1016/j.ijpharm.2016.09.057", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "DOI": "10.1016/j.ijpharm.2009.06.006", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "DOI": "10.1073/pnas.1422923112", "doi-asserted-by": "publisher"}, {"key": "CIT0081", "DOI": "10.1016/j.nano.2015.11.002", "doi-asserted-by": "publisher"}, {"key": "CIT0082", "DOI": "10.1016/j.ejps.2011.10.003", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "DOI": "10.1128/JVI.75.19.9037-9043.2001", "doi-asserted-by": "publisher"}, {"key": "CIT0084", "DOI": "10.3390/pharmaceutics5030392", "doi-asserted-by": "publisher"}, {"key": "CIT0085", "DOI": "10.1016/j.jconrel.2016.01.050", "doi-asserted-by": "publisher"}, {"key": "CIT0086", "DOI": "10.1371/journal.pone.0017642", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "DOI": "10.1007/s11095-015-1701-7", "doi-asserted-by": "publisher"}, {"key": "CIT0088", "DOI": "10.1073/pnas.1104264108", "doi-asserted-by": "publisher"}, {"key": "CIT0089", "DOI": "10.1371/journal.pone.0010051", "doi-asserted-by": "publisher"}, {"key": "CIT0090", "DOI": "10.1016/j.jconrel.2016.05.033", "doi-asserted-by": "publisher"}, {"key": "CIT0091", "DOI": "10.1016/j.jconrel.2015.09.069", "doi-asserted-by": "publisher"}, {"key": "CIT0092", "author": "Fadeel B", "volume": "142", "first-page": "w13609", "year": "2012", "journal-title": "Swiss Med Wkly"}, {"key": "CIT0093", "DOI": "10.1021/ja2108905", "doi-asserted-by": "publisher"}, {"key": "CIT0094", "DOI": "10.1002/anie.201710068", "doi-asserted-by": "publisher"}, {"key": "CIT0096", "DOI": "10.1517/17425247.2015.1044435", "doi-asserted-by": "publisher"}], "container-title": ["Drug Development and Industrial Pharmacy"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1080/03639045.2019.1583758", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T17:00:51Z", "timestamp": 1557421251000}, "score": 21.57406, "issued": {"date-parts": [[2019, 3]]}, "references-count": 94, "journal-issue": {"published-online": {"date-parts": [[2019, 3, 19]]}, "published-print": {"date-parts": [[2019, 6, 3]]}, "issue": "6"}, "alternative-id": ["10.1080/03639045.2019.1583758"], "URL": "http://dx.doi.org/10.1080/03639045.2019.1583758", "relation": {"cites": []}, "ISSN": ["0363-9045", "1520-5762"], "issn-type": [{"value": "0363-9045", "type": "print"}, {"value": "1520-5762", "type": "electronic"}], "subject": ["Organic Chemistry", "Pharmacology", "Drug Discovery"], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iddi20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iddi20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}, {"value": "2018-12-19", "order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2019-02-06", "order": 1, "name": "revised", "label": "Revised", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2019-02-12", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2019-02-15", "order": 3, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:50:11Z", "timestamp": 1574520611259}, "reference-count": 90, "publisher": "Elsevier BV", "issue": "10-11", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 9, 1]], "date-time": "2011-09-01T00:00:00Z", "timestamp": 1314835200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advanced Drug Delivery Reviews"], "published-print": {"date-parts": [[2011, 9]]}, "DOI": "10.1016/j.addr.2011.05.016", "type": "journal-article", "created": {"date-parts": [[2011, 6, 24]], "date-time": "2011-06-24T09:44:15Z", "timestamp": 1308908655000}, "page": "890-900", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Targeting the lymphatics using dendritic polymers (dendrimers)"], "prefix": "10.1016", "volume": "63", "author": [{"given": "Lisa M.", "family": "Kaminskas", "sequence": "first", "affiliation": []}, {"given": "Christopher J.H.", "family": "Porter", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Advanced Drug Delivery Reviews"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169409X11001384?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169409X11001384?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 12]], "date-time": "2019-06-12T05:52:03Z", "timestamp": 1560318723000}, "score": 20.061832, "issued": {"date-parts": [[2011, 9]]}, "references-count": 90, "journal-issue": {"published-print": {"date-parts": [[2011, 9]]}, "issue": "10-11"}, "alternative-id": ["S0169409X11001384"], "URL": "http://dx.doi.org/10.1016/j.addr.2011.05.016", "ISSN": ["0169-409X"], "issn-type": [{"value": "0169-409X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T21:55:03Z", "timestamp": 1574805303248}, "reference-count": 129, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 9, 1]], "date-time": "2017-09-01T00:00:00Z", "timestamp": 1504224000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Current Opinion in Colloid & Interface Science"], "published-print": {"date-parts": [[2017, 9]]}, "DOI": "10.1016/j.cocis.2017.06.003", "type": "journal-article", "created": {"date-parts": [[2017, 7, 4]], "date-time": "2017-07-04T02:47:02Z", "timestamp": 1499136422000}, "page": "18-29", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Polymer-drug conjugates as inhalable drug delivery systems: A review"], "prefix": "10.1016", "volume": "31", "author": [{"given": "Nirmal", "family": "Marasini", "sequence": "first", "affiliation": []}, {"given": "Shadabul", "family": "Haque", "sequence": "additional", "affiliation": []}, {"given": "Lisa M.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Current Opinion in Colloid & Interface Science"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359029417300511?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359029417300511?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 28]], "date-time": "2019-09-28T09:16:16Z", "timestamp": 1569662176000}, "score": 20.061832, "issued": {"date-parts": [[2017, 9]]}, "references-count": 129, "alternative-id": ["S1359029417300511"], "URL": "http://dx.doi.org/10.1016/j.cocis.2017.06.003", "ISSN": ["1359-0294"], "issn-type": [{"value": "1359-0294", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Polymer-drug conjugates as inhalable drug delivery systems: A review", "name": "articletitle", "label": "Article Title"}, {"value": "Current Opinion in Colloid & Interface Science", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.cocis.2017.06.003", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Crown Copyright \u00a9 2017 Published by Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:39:42Z", "timestamp": 1574865582908}, "reference-count": 0, "publisher": "US Geological Survey", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.3133/ofr791159", "type": "other", "created": {"date-parts": [[2018, 8, 14]], "date-time": "2018-08-14T22:12:25Z", "timestamp": 1534284745000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Geological and operational summary, COST No. B-3 well, Baltimore Canyon Trough area, Mid-Atlantic OCS"], "prefix": "10.3133", "author": [{"given": "Roger V.", "family": "Amato", "sequence": "first", "affiliation": []}, {"given": "Edvardas K.", "family": "Simonis", "sequence": "additional", "affiliation": []}], "member": "1689", "published-online": {"date-parts": [[1979]]}, "container-title": ["Open-File Report"], "deposited": {"date-parts": [[2019, 4, 30]], "date-time": "2019-04-30T18:24:35Z", "timestamp": 1556648675000}, "score": 19.56704, "issued": {"date-parts": [[1979]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3133/ofr791159", "ISSN": ["2331-1258"], "issn-type": [{"value": "2331-1258", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T13:08:34Z", "timestamp": 1574514514102}, "publisher-location": "Dordrecht", "reference-count": 44, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789400712478", "type": "print"}, {"value": "9789400712485", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-94-007-1248-5_6", "type": "book-chapter", "created": {"date-parts": [[2011, 5, 25]], "date-time": "2011-05-25T15:56:03Z", "timestamp": 1306338963000}, "page": "155-178", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Nanosized Drug Delivery Vectors and the Reticuloendothelial System"], "prefix": "10.1007", "author": [{"given": "Lisa M.", "family": "Kaminskas", "sequence": "first", "affiliation": []}, {"given": "Ben J.", "family": "Boyd", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 4, 27]]}, "reference": [{"key": "6_CR1_6", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.1128/AAC.38.3.588", "volume": "38", "author": "A Agarwal", "year": "1994", "unstructured": "A. Agarwal, H. Kandpal, H.P. Gupta, N.B. Singh, C.M. Gupta, Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice, Antimicrobial Agents and Chemotherapy, 38 (1994) 588\u2013593.", "journal-title": "Antimicrobial Agents and Chemotherapy"}, {"key": "6_CR2_6", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1016/j.nano.2007.02.002", "volume": "3", "author": "HB Agashe", "year": "2007", "unstructured": "H.B. Agashe, A.K. Babbar, S. Jain, R.K. Sharma, A.K. Mishra, A. Asthana, M. Garg, T. Dutta, N.K. Jain, Investigations on biodiostribution of technetium-99 m-labelled carbohydrate-coated poly (propylene imine) dendrimers, Nanomedicine: Nanotechnology, Biology and Medicine, 3 (2007) 120\u2013127.", "journal-title": "Nanomedicine: Nanotechnology, Biology and Medicine"}, {"key": "6_CR3_6", "doi-asserted-by": "publisher", "first-page": "1696", "DOI": "10.1021/bc900047n", "volume": "20", "author": "WT Al Jamal", "year": "2009", "unstructured": "W.T. Al Jamal, K.T. Al Jamal, A. Cakebread, J.M. Halket, K. Kostarelos, Blood circulation and tissue biodistribution of lipid-quantum dot (L-QD) hybrid vesicles intravenously administered in mice, Bioconjugate Chemistry, 20 (2009) 1696\u20131702.", "journal-title": "Bioconjugate Chemistry"}, {"key": "6_CR4_6", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1016/0005-2736(91)90268-D", "volume": "1061", "author": "TM Allen", "year": "1991", "unstructured": "T.M. Allen, G.A. Austin, A. Chonn, L. Lin, K.C. Lee, Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size, Biochimica et Biophysica Acta, 1061 (1991a) 56\u201364.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR5_6", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1016/0005-2736(91)90246-5", "volume": "1066", "author": "TM Allen", "year": "1991", "unstructured": "T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yau-Young, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half lives in vivo, Biochimica et Biophysica Acta, 1066 (1991b) 29\u201336.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR6_6", "doi-asserted-by": "publisher", "first-page": "614", "DOI": "10.1021/mp060032e", "volume": "3", "author": "BJ Boyd", "year": "2006", "unstructured": "B.J. Boyd, L.M. Kaminskas, P. Karellas, G. Krippner, R. Lessene, C.J.H. Porter, Cationic poly-L-lysine dendrimers: Pharmacokinetics, biodistribution and evidence for metabolism and bioresorption after intravenous administration in rats., Molecular Pharmaceutics, 3 (2006) 614\u2013627.", "journal-title": "Molecular Pharmaceutics"}, {"key": "6_CR7_6", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1016/S0005-2736(99)00137-6", "volume": "1421", "author": "I Dufresne", "year": "1999", "unstructured": "I. Dufresne, A. Desormeaux, J. Bestman-Smith, P. Gourde, M.J. Tremblay, M.G. Bergeron, Targeting lymph nodes with liposome bearing anti-HLA-DR-Fab\u2019 fragments, Biochimica et Biophysica Acta, 1421 (1999) 284\u2013294.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR8_6", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/j.ejps.2008.04.002", "volume": "34", "author": "T Dutta", "year": "2008", "unstructured": "T. Dutta, M. Garg, N.K. Jain, targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro, European Journal of Pharmaceutical Sciences, 34 (2008) 181\u2013189.", "journal-title": "European Journal of Pharmaceutical Sciences"}, {"key": "6_CR9_6", "doi-asserted-by": "publisher", "first-page": "772", "DOI": "10.1002/jgm.1366", "volume": "11", "author": "A Egorova", "year": "2009", "unstructured": "A. Egorova, A. Kiselev, M. Hakli, M. Ruponen, V. Baranov, A. Urtti, Chemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cells, Journal of Gene Medicine, 11 (2009) 772\u2013781.", "journal-title": "Journal of Gene Medicine"}, {"key": "6_CR10_6", "first-page": "891", "volume": "52", "author": "AA Gabizon", "year": "1992", "unstructured": "A.A. Gabizon, Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes, Cancer Research, 52 (1992) 891\u2013896.", "journal-title": "Cancer Research"}, {"key": "6_CR11_6", "doi-asserted-by": "publisher", "first-page": "6949", "DOI": "10.1073/pnas.85.18.6949", "volume": "85", "author": "A Gabizon", "year": "1988", "unstructured": "A. Gabizon, D. Papahadjopoulos, Liposome frmulations with prolonged circulation time in blood and enhanced uptake by tumors, Proceedings of the National Academy of Science USA, 85 (1988) 6949\u20136953.", "journal-title": "Proceedings of the National Academy of Science U S A"}, {"key": "6_CR12_6", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1016/0005-2736(92)90061-P", "volume": "1103", "author": "A Gabizon", "year": "1992", "unstructured": "A. Gabizon, D. Papahadjopoulos, The role of surface charge and hydrophilic groups on liposome clearance in vivo, Biochimica et Biophysica Acta, 1103 (1992) 94\u2013100.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR13_6", "doi-asserted-by": "publisher", "first-page": "1484", "DOI": "10.1093/jnci/81.19.1484", "volume": "81", "author": "A Gabizon", "year": "1989", "unstructured": "A. Gabizon, R. Shiota, D. Papahadjopoulos, Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times, Journal of the National Cancer Institute, 81 (1989) 1484\u20131488.", "journal-title": "Journal of the National Cancer Institute"}, {"key": "6_CR14_6", "first-page": "6371", "volume": "50", "author": "A Gabizon", "year": "1990", "unstructured": "A. Gabizon, D.C. Price, J. Huberty, R.S. Bresalier, D. Papahadjopoulos, Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies, Cancer Research, 50 (1990) 6371\u20136378.", "journal-title": "Cancer Research"}, {"key": "6_CR15_6", "doi-asserted-by": "publisher", "first-page": "703", "DOI": "10.1517/17425247.5.6.703", "volume": "5", "author": "JM Irache", "year": "2008", "unstructured": "J.M. Irache, H.H. Salman, C. Gamazo, S. Espuelas, Mannose-targeted systems for the delivery of therapeutics, Expert Opinion in Drug Delivery, 5 (2008) 703\u2013724.", "journal-title": "Expert Opinion in Drug Delivery"}, {"key": "6_CR16_6", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/j.nano.2007.11.004", "volume": "4", "author": "SK Jain", "year": "2008", "unstructured": "S.K. Jain, Y. Gupta, A. Jain, A.R. Saxena, P. Khare, A. Jain, Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery, Nanomedicine, 4 (2008) 41\u201348.", "journal-title": "Nanomedicine"}, {"key": "6_CR17_6", "doi-asserted-by": "publisher", "first-page": "949", "DOI": "10.1021/mp070047s", "volume": "4", "author": "LM Kaminskas", "year": "2007", "unstructured": "L.M. Kaminskas, B.J. Boyd, P. Karellas, S.A. Henderson, M.P. Giannis, G. Krippner, C.J. Porter, Impact of surface derivatisation of poly-L-lysine dendrimers with anionic arylsulphonate or succinate groups on intravenous pharmacokinetics and disposition, Molecular Pharmaceutics, 4 (2007) 949\u2013961.", "journal-title": "Molecular Pharmaceutics"}, {"key": "6_CR18_6", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1021/mp7001208", "volume": "5", "author": "LM Kaminskas", "year": "2008", "unstructured": "L.M. Kaminskas, B.J. Boyd, P. Karellas, G.Y. Krippner, R. Lessene, B. Kelly, C.J.H. Porter, The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly-L-lysine dendrimers, Molecular Pharmaceutics, 5 (2008) 449\u2013463.", "journal-title": "Molecular Pharmaceutics"}, {"key": "6_CR19_6", "doi-asserted-by": "publisher", "first-page": "1190", "DOI": "10.1021/mp900049a", "volume": "6", "author": "LM Kaminskas", "year": "2009", "unstructured": "L.M. Kaminskas, B. Kelly, V. McLeod, B.J. Boyd, G.Y. Krippner, E.D. Williams, C.J.H. Porter, Pharmacokinetics and tumour disposition of PEGylated methotrexate conjugated poly-L-lysine dendrimers, Molecular Pharmaceutics, 6 (2009a) 1190\u20131204.", "journal-title": "Molecular Pharmaceutics"}, {"key": "6_CR20_6", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1016/j.jconrel.2009.08.005", "volume": "140", "author": "LM Kaminskas", "year": "2009", "unstructured": "L.M. Kaminskas, J. Kota, V.M. McLeod, B.D. Kelly, P. Karellas, C.J.H. Porter, PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats, Journal of Controlled Release, 140 (2009b) 108\u2013116.", "journal-title": "Journal of Controlled Release"}, {"key": "6_CR21_6", "doi-asserted-by": "publisher", "first-page": "798", "DOI": "10.1080/10611860802475688", "volume": "16", "author": "CD Kaur", "year": "2008", "unstructured": "C.D. Kaur, M.H. Nahar, N.K. Jain, Lymphatic targeting of zidovudine using surface-engineered liposomes, Journal of Drug Targeting, 16 (2008) 798\u2013805.", "journal-title": "Journal of Drug Targeting"}, {"key": "6_CR22_6", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1016/S0304-4165(00)00163-X", "volume": "1524", "author": "S Kawakami", "year": "2000", "unstructured": "S. Kawakami, J. Wong, A. Sato, Y. Hattori, F. Yamashita, M. Hashida, Biodistribution characteristics of mannosylated, fucosylated and galactosylated liposomes in mice, Biochimica et Biophysica Acta, 1524 (2000) 258\u2013265.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR23_6", "doi-asserted-by": "publisher", "first-page": "993", "DOI": "10.1038/mt.2010.27", "volume": "18", "author": "SS Kim", "year": "2010", "unstructured": "S.S. Kim, C. Ye, P. Kumar, I. Chiu, S. Subramanya, P. Shankar, N. Manjunath, Targeted delivery of siRNA to macrophages for anti-inflammatory treatment, Molecular Therapeutics, 18 (2010) 993\u20131001.", "journal-title": "Molecular Therapeutics"}, {"key": "6_CR24_6", "doi-asserted-by": "publisher", "first-page": "705", "DOI": "10.1002/jmri.10025", "volume": "14", "author": "H Kobayashi", "year": "2001", "unstructured": "H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, J. Konishi, K. Togashi, M.W. Brechbiel, Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents, Journal of Magnetic Resonance Imaging, 14 (2001a) 705\u2013713.", "journal-title": "Journal of Magnetic Resonance Imaging"}, {"key": "6_CR25_6", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.1002/mrm.1259", "volume": "46", "author": "H Kobayashi", "year": "2001", "unstructured": "H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, Y. Akita, M.H. Mamede, J. Konishi, K. Togashi, Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core, Magnetic Resonance in Medicine, 46 (2001b) 795\u2013802.", "journal-title": "Magnetic Resonance in Medicine"}, {"key": "6_CR26_6", "doi-asserted-by": "publisher", "first-page": "758", "DOI": "10.1002/mrm.10583", "volume": "50", "author": "H Kobayashi", "year": "2003", "unstructured": "H. Kobayashi, S. Kawamoto, P.L. Choyke, N. Sato, M.V. Knopp, R.A. Star, T.A. Waldmann, Y. Tagaya, M.W. Brechbiel, Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography, Magnetic Resonance in Medicine, 50 (2003) 758\u2013766.", "journal-title": "Magnetic Resonance in Medicine"}, {"key": "6_CR27_6", "doi-asserted-by": "publisher", "first-page": "343", "DOI": "10.1016/j.jconrel.2005.12.019", "volume": "111", "author": "H Kobayashi", "year": "2006", "unstructured": "H. Kobayashi, S. Kawamoto, M. Bernardo, M.W. Brechbiel, M.V. Knopp, P.L. Choyke, Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging, Journal of Controlled Release, 111 (2006) 343\u2013351.", "journal-title": "Journal of Controlled Release"}, {"key": "6_CR28_6", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1016/0005-2736(94)90038-8", "volume": "1190", "author": "DC Litzinger", "year": "1994", "unstructured": "D.C. Litzinger, A.M. Buiting, N. Van Rooijen, L. Huang, Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes, Biochimica et Biophysica Acta, 1190 (1994) 99\u2013107.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR29_6", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.1016/0005-2736(95)00196-4", "volume": "1278", "author": "F Liu", "year": "1996", "unstructured": "F. Liu, D. Liu, Serum independent liposome uptake by mouse liver, Biochimica et Biophysica Acta, 1278 (1996) 5\u201311.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR30_6", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1016/0005-2736(95)00005-N", "volume": "1235", "author": "D Liu", "year": "1995", "unstructured": "D. Liu, F. Liu, Y.K. Song, Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin, Biochimica et Biophysica Acta, 1235 (1995a) 140\u2013146.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR31_6", "doi-asserted-by": "publisher", "first-page": "508", "DOI": "10.1023/A:1016289526578", "volume": "12", "author": "D Liu", "year": "1995", "unstructured": "D. Liu, F. Liu, Y.K. Song, Monosialoganglioside GM1 shortens the blood circulation of liposomes in rats, Pharmaceutical Research, 12 (1995b) 508\u2013512.", "journal-title": "Pharmaceutical Research"}, {"key": "6_CR32_6", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1016/S0167-4889(02)00204-5", "volume": "1590", "author": "SM Moghimi", "year": "2002", "unstructured": "S.M. Moghimi, Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers, Biochimica et Biophysica Acta, 1590 (2002) 131\u2013139.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR33_6", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/BF00205750", "volume": "27", "author": "K Morikawa", "year": "1988", "unstructured": "K. Morikawa, R. Nayar, I.J. Fidler, In vitro activation of tumoricidal properties in mouse \u00admacrophages using the chemotactic peptide N-formyl-methionyl-phenylalanine (FMLP) incorporated in liposomes, Cancer Immunology and Immunotherapy, 27 (1988) 1\u20136.", "journal-title": "Cancer Immunology and Immunotherapy"}, {"key": "6_CR34_6", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1089/lrb.2007.5302", "volume": "5", "author": "R Mounzer", "year": "2007", "unstructured": "R. Mounzer, P. Shakarin, X. Papademetris, T. Constable, N.H. Ruddle, T.M. Fahmy, Dynamic imaging of lymphatic vessles and lymph nodes using a bimodal nanoparticulate contrast agent, Lymphatic Research and Biology, 5 (2007) 151\u2013158.", "journal-title": "Lymphatic Research and Biology"}, {"key": "6_CR35_6", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.3109/10611869908996849", "volume": "6", "author": "A Nag", "year": "1999", "unstructured": "A. Nag, P.C. Ghosh, Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver, Journal of Drug Targeting, 6 (1999) 427\u2013438.", "journal-title": "Journal of Drug Targeting"}, {"key": "6_CR36_6", "doi-asserted-by": "publisher", "first-page": "777", "DOI": "10.3109/10611860903115308", "volume": "17", "author": "N Nimje", "year": "2009", "unstructured": "N. Nimje, A. Agarwal, G.K. Saraogi, N. Lariya, G. Rai, H. Agarwal, G.P. Agarwal, Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting, Journal of Drug Targeting, 17 (2009) 777\u2013787.", "journal-title": "Journal of Drug Targeting"}, {"key": "6_CR37_6", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/0005-2760(92)90238-Q", "volume": "1126", "author": "N Oku", "year": "1992", "unstructured": "N. Oku, Y. Namba, S. Okada, Tumor accumulation of novel RES-avoiding liposomes, Biochimica et Biophysica Acta, 1126 (1992) 255\u2013260.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR38_6", "doi-asserted-by": "publisher", "first-page": "1479", "DOI": "10.1023/A:1012145410859", "volume": "14", "author": "C Oussoren", "year": "1997", "unstructured": "C. Oussoren, G. Storm, Lymphatic uptake and biodistributions of liposomes after subcutaneous injection: III. influence of surface modification with poly(ethyleneglycol), Pharmaceutical Research, 14 (1997) 1479\u20131484.", "journal-title": "Pharmaceutical Research"}, {"key": "6_CR39_6", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/S0169-409X(01)00154-5", "volume": "50", "author": "C Oussoren", "year": "2001", "unstructured": "C. Oussoren, G. Storm, Liposomes to target the lymphatics by subcutaneous administration, Advanced Drug Delivery Reviews, 50 (2001) 143\u2013156.", "journal-title": "Advanced Drug Delivery Reviews"}, {"key": "6_CR40_6", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.2174/157016306778108893", "volume": "3", "author": "PC Rensen", "year": "2006", "unstructured": "P.C. Rensen, J.C. Gras, E.K. Lindfors, K.W. van Dijk, J.W. Jukema, T.J. van Berkel, E.A. Biessen, Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A, Current Drug Discovery Technologies, 3 (2006) 135\u2013144.", "journal-title": "Current Drug Discovery Technologies"}, {"key": "6_CR41_6", "doi-asserted-by": "publisher", "first-page": "224", "DOI": "10.1016/0005-2736(86)90262-2", "volume": "863", "author": "HH Spanjer", "year": "1986", "unstructured": "H.H. Spanjer, M. van Galen, F.H. Roerdink, J. Regts, G.L. Scherphof, Intrahepatic distribution of small unilamellar liposomes as a function of liposome lipid composition, Biochimica et Biophysica Acta, 863 (1986) 224\u2013230.", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "6_CR42_6", "doi-asserted-by": "publisher", "first-page": "1409", "DOI": "10.1016/S0142-9612(02)00525-2", "volume": "24", "author": "L Thiele", "year": "2003", "unstructured": "L. Thiele, J.E. Deiederichs, R. Reszka, H.P. Merkle, E. Walter, Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells, Biomaterials, 24 (2003) 1409\u20131418.", "journal-title": "Biomaterials"}, {"key": "6_CR43_6", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0378-5173(00)00522-6", "volume": "210", "author": "SP Vyas", "year": "2000", "unstructured": "S.P. Vyas, Y.K. Katare, V. Mishra, V. Sihorkar, Ligand directed macrophage targeting of amphotericin B loaded liposomes, International Journal of Pharmaceutics, 210 (2000) 1\u201314.", "journal-title": "International Journal of Pharmaceutics"}, {"key": "6_CR44_6", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1021/bc070066k", "volume": "19", "author": "L Wan", "year": "2008", "unstructured": "L. Wan, X. Zhang, S. Pooyan, M.S. Palombo, M.J. Leibowitz, S. Stein, P.J. Sinko, Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages, Bioconjugate Chemistry, 19 (2008) 28\u201338.", "journal-title": "Bioconjugate Chemistry"}], "container-title": ["Intracellular Delivery", "Fundamental Biomedical Technologies"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-94-007-1248-5_6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T12:08:28Z", "timestamp": 1572869308000}, "score": 18.861763, "issued": {"date-parts": [[2011]]}, "ISBN": ["9789400712478", "9789400712485"], "references-count": 44, "URL": "http://dx.doi.org/10.1007/978-94-007-1248-5_6", "relation": {"cites": []}, "ISSN": ["1559-7083"], "issn-type": [{"value": "1559-7083", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T02:42:15Z", "timestamp": 1574736135310}, "reference-count": 280, "publisher": "Springer Science and Business Media LLC", "issue": "11", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 10, 16]], "date-time": "2015-10-16T00:00:00Z", "timestamp": 1444953600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Nat Rev Drug Discov"], "published-print": {"date-parts": [[2015, 11]]}, "DOI": "10.1038/nrd4608", "type": "journal-article", "created": {"date-parts": [[2015, 10, 16]], "date-time": "2015-10-16T06:23:14Z", "timestamp": 1444976594000}, "page": "781-803", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 140, "title": ["From sewer to saviour \u2014 targeting the lymphatic system to promote drug exposure and activity"], "prefix": "10.1038", "volume": "14", "author": [{"given": "Natalie L.", "family": "Trevaskis", "sequence": "first", "affiliation": []}, {"given": "Lisa M.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "Christopher J. H.", "family": "Porter", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 10, 16]]}, "reference": [{"key": "BFnrd4608_CR1", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1038/nri3298", "volume": "12", "author": "JP Girard", "year": "2012", "unstructured": "Girard, J. P., Moussion, C. & Forster, R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12, 762\u2013773 (2012).", "journal-title": "Nat. Rev. Immunol."}, {"key": "BFnrd4608_CR2", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1172/JCI71610", "volume": "124", "author": "GJ Randolph", "year": "2014", "unstructured": "Randolph, G. J. & Miller, N. E. Lymphatic transport of high-density lipoproteins and chylomicrons. J. Clin. Invest. 124, 929\u2013935 (2014).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR3", "doi-asserted-by": "crossref", "first-page": "E659", "DOI": "10.1152/ajpendo.00058.2011", "volume": "301", "author": "NE Miller", "year": "2011", "unstructured": "Miller, N. E. et al. Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport. Am. J. Physiol. Endocrinol. Metab. 301, E659\u2013E667 (2011).", "journal-title": "Am. J. Physiol. Endocrinol. Metab."}, {"key": "BFnrd4608_CR4", "doi-asserted-by": "crossref", "first-page": "1005", "DOI": "10.1152/physrev.00037.2011", "volume": "92", "author": "H Wiig", "year": "2012", "unstructured": "Wiig, H. & Swartz, M. A. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol. Rev. 92, 1005\u20131060 (2012).", "journal-title": "Physiol. Rev."}, {"key": "BFnrd4608_CR5", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1113/jphysiol.1896.sp000596", "volume": "19", "author": "EH Starling", "year": "1896", "unstructured": "Starling, E. H. On the absorption of fluids from the connective tissue spaces. J. Physiol. 19, 312\u2013326 (1896).", "journal-title": "J. Physiol."}, {"key": "BFnrd4608_CR6", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1093/cvr/cvq062", "volume": "87", "author": "JR Levick", "year": "2010", "unstructured": "Levick, J. R. & Michel, C. C. Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87, 198\u2013210 (2010).", "journal-title": "Cardiovasc. Res."}, {"key": "BFnrd4608_CR7", "doi-asserted-by": "crossref", "first-page": "915", "DOI": "10.1172/JCI71608", "volume": "124", "author": "PS Mortimer", "year": "2014", "unstructured": "Mortimer, P. S. & Rockson, S. G. New developments in clinical aspects of lymphatic disease. J. Clin. Invest. 124, 915\u2013921 (2014).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR8", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1172/JCI73316", "volume": "124", "author": "CM Card", "year": "2014", "unstructured": "Card, C. M., Yu, S. S. & Swartz, M. A. Emerging roles of lymphatic endothelium in regulating adaptive immunity. J. Clin. Invest. 124, 943\u2013952 (2014).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR9", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1038/mi.2012.4", "volume": "5", "author": "O Pabst", "year": "2012", "unstructured": "Pabst, O. & Mowat, A. M. Oral tolerance to food protein. Mucosal Immunol. 5, 232\u2013239 (2012).", "journal-title": "Mucosal Immunol."}, {"key": "BFnrd4608_CR10", "doi-asserted-by": "crossref", "first-page": "580", "DOI": "10.1016/j.cmet.2010.11.002", "volume": "12", "author": "L Lichtenstein", "year": "2010", "unstructured": "Lichtenstein, L. et al. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell. Metabolism 12, 580\u2013592 (2010).", "journal-title": "Cell. Metabolism"}, {"key": "BFnrd4608_CR11", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1084/jem.20060227", "volume": "203", "author": "AJ Macpherson", "year": "2006", "unstructured": "Macpherson, A. J. & Smith, K. Mesenteric lymph nodes at the center of immune anatomy. J. Exp. Med. 203, 497\u2013500 (2006).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4608_CR12", "doi-asserted-by": "crossref", "first-page": "480", "DOI": "10.1016/j.tem.2010.04.003", "volume": "21", "author": "JB Dixon", "year": "2010", "unstructured": "Dixon, J. B. Lymphatic lipid transport: sewer or subway? Trends Endocrinol. Metab. 21, 480\u2013487 (2010).", "journal-title": "Trends Endocrinol. Metab."}, {"key": "BFnrd4608_CR13", "doi-asserted-by": "crossref", "first-page": "1571", "DOI": "10.1172/JCI63685", "volume": "123", "author": "C Martel", "year": "2013", "unstructured": "Martel, C. et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J. Clin. Invest. 123, 1571\u20131579 (2013). A report on the important role of lymphatic vessels in facilitating HDL-mediated reverse cholesterol transport from tissues and atherosclerotic plaques to the systemic circulation, ultimately for excretion via the liver.", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR14", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1016/j.cmet.2013.04.002", "volume": "17", "author": "HY Lim", "year": "2013", "unstructured": "Lim, H. Y. et al. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell. Metabolism 17, 671\u2013684 (2013). This article confirms the important role of lymphatic vessels in facilitating HDL-mediated reverse cholesterol transport from tissues, and provides evidence that HDL enters the lymphatics by active transcytosis across LECs via SRB1.", "journal-title": "Cell. Metabolism"}, {"key": "BFnrd4608_CR15", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1196/annals.1413.007", "volume": "1131", "author": "NL Harvey", "year": "2008", "unstructured": "Harvey, N. L. The link between lymphatic function and adipose biology. Ann. NY Acad. Sci. 1131, 82\u201388 (2008).", "journal-title": "Ann. NY Acad. Sci."}, {"key": "BFnrd4608_CR16", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/j.plefa.2005.04.005", "volume": "73", "author": "CM Pond", "year": "2005", "unstructured": "Pond, C. M. Adipose tissue and the immune system. Prostaglandins Leukot. Essent. Fatty Acids 73, 17\u201330 (2005).", "journal-title": "Prostaglandins Leukot. Essent. Fatty Acids"}, {"key": "BFnrd4608_CR17", "doi-asserted-by": "crossref", "first-page": "1072", "DOI": "10.1038/ng1642", "volume": "37", "author": "NL Harvey", "year": "2005", "unstructured": "Harvey, N. L. et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 37, 1072\u20131081 (2005). This report highlights the links between lymphatics and adipose function and the development of obesity.", "journal-title": "Nat. Genet."}, {"key": "BFnrd4608_CR18", "doi-asserted-by": "crossref", "first-page": "1970", "DOI": "10.2337/db12-0604", "volume": "62", "author": "M Sawane", "year": "2013", "unstructured": "Sawane, M. et al. Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes 62, 1970\u20131980 (2013).", "journal-title": "Diabetes"}, {"key": "BFnrd4608_CR19", "doi-asserted-by": "crossref", "first-page": "e94713", "DOI": "10.1371/journal.pone.0094713", "volume": "9", "author": "KS Blum", "year": "2014", "unstructured": "Blum, K. S. et al. Chronic high-fat diet impairs collecting lymphatic vessel function in mice. PLoS ONE 9, e94713 (2014).", "journal-title": "PLoS ONE"}, {"key": "BFnrd4608_CR20", "doi-asserted-by": "crossref", "first-page": "748", "DOI": "10.1038/ijo.2012.98", "volume": "37", "author": "N Arngrim", "year": "2013", "unstructured": "Arngrim, N., Simonsen, L., Holst, J. J. & Bulow, J. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation? Int. J. Obes. 37, 748\u2013750 (2013).", "journal-title": "Int. J. Obes."}, {"key": "BFnrd4608_CR21", "doi-asserted-by": "crossref", "first-page": "H165", "DOI": "10.1152/ajpheart.00244.2014", "volume": "307", "author": "IL Savetsky", "year": "2014", "unstructured": "Savetsky, I. L. et al. Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema. Am. J. Physiol. Heart Circ. Physiol. 307, H165\u2013H172 (2014).", "journal-title": "Am. J. Physiol. Heart Circ. Physiol."}, {"key": "BFnrd4608_CR22", "doi-asserted-by": "crossref", "first-page": "e70703", "DOI": "10.1371/journal.pone.0070703", "volume": "8", "author": "ES Weitman", "year": "2013", "unstructured": "Weitman, E. S. et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS ONE 8, e70703 (2013).", "journal-title": "PLoS ONE"}, {"key": "BFnrd4608_CR23", "doi-asserted-by": "crossref", "first-page": "1261", "DOI": "10.1038/oby.2008.55", "volume": "16", "author": "CS Kim", "year": "2008", "unstructured": "Kim, C. S. et al. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity 16, 1261\u20131269 (2008).", "journal-title": "Obesity"}, {"key": "BFnrd4608_CR24", "doi-asserted-by": "crossref", "first-page": "1371", "DOI": "10.1038/nm.2545", "volume": "17", "author": "K Alitalo", "year": "2011", "unstructured": "Alitalo, K. The lymphatic vasculature in disease. Nat. Med. 17, 1371\u20131380 (2011). A review of advances in our current understanding of the role of lymphatics in pathological change and disease.", "journal-title": "Nat. Med."}, {"key": "BFnrd4608_CR25", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1002/wsbm.1201", "volume": "5", "author": "CT Kesler", "year": "2013", "unstructured": "Kesler, C. T., Liao, S., Munn, L. L. & Padera, T. P. Lymphatic vessels in health and disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 5, 111\u2013124 (2013).", "journal-title": "Wiley Interdiscip. Rev. Syst. Biol. Med."}, {"key": "BFnrd4608_CR26", "doi-asserted-by": "crossref", "first-page": "2115", "DOI": "10.1101/gad.1955910", "volume": "24", "author": "Y Wang", "year": "2010", "unstructured": "Wang, Y. & Oliver, G. Current views on the function of the lymphatic vasculature in health and disease. Genes Dev. 24, 2115\u20132126 (2010).", "journal-title": "Genes Dev."}, {"key": "BFnrd4608_CR27", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1038/nrc3186", "volume": "12", "author": "MA Swartz", "year": "2012", "unstructured": "Swartz, M. A. & Lund, A. W. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat. Rev. Cancer 12, 210\u2013219 (2012).", "journal-title": "Nat. Rev. Cancer"}, {"key": "BFnrd4608_CR28", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1007/s10456-013-9406-1", "volume": "17", "author": "LC Dieterich", "year": "2014", "unstructured": "Dieterich, L. C., Seidel, C. D. & Detmar, M. Lymphatic vessels: new targets for the treatment of inflammatory diseases. Angiogenesis 17, 359\u2013371 (2014).", "journal-title": "Angiogenesis"}, {"key": "BFnrd4608_CR29", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1016/j.jconrel.2013.04.027", "volume": "172", "author": "ST Proulx", "year": "2013", "unstructured": "Proulx, S. T. et al. Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery. J. Control. Release 172, 550\u2013557 (2013).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR30", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1097/MOG.0b013e3283476e8f", "volume": "27", "author": "PY von der Weid", "year": "2011", "unstructured": "von der Weid, P. Y., Rehal, S. & Ferraz, J. G. Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr. Opin. Gastroenterol. 27, 335\u2013341 (2011).", "journal-title": "Curr. Opin. Gastroenterol."}, {"key": "BFnrd4608_CR31", "doi-asserted-by": "crossref", "first-page": "3863", "DOI": "10.1172/JCI72189", "volume": "124", "author": "S Alessio", "year": "2014", "unstructured": "Alessio, S. et al. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J. Clin. Invest. 124, 3863\u20133878 (2014).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR32", "doi-asserted-by": "crossref", "first-page": "4667", "DOI": "10.1182/blood-2010-10-316356", "volume": "117", "author": "R Huggenberger", "year": "2011", "unstructured": "Huggenberger, R. et al. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117, 4667\u20134678 (2011).", "journal-title": "Blood"}, {"key": "BFnrd4608_CR33", "doi-asserted-by": "crossref", "first-page": "R118", "DOI": "10.1186/ar2326", "volume": "9", "author": "Q Zhang", "year": "2007", "unstructured": "Zhang, Q. et al. Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Res. Ther. 9, R118 (2007).", "journal-title": "Arthritis Res. Ther."}, {"key": "BFnrd4608_CR34", "first-page": "2954", "volume": "119", "author": "P Baluk", "year": "2009", "unstructured": "Baluk, P. et al. TNF-\u03b1 drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J. Clin. Invest. 119, 2954\u20132964 (2009).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR35", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1038/nm.1960", "volume": "15", "author": "A Machnik", "year": "2009", "unstructured": "Machnik, A. et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15, 545\u2013552 (2009).", "journal-title": "Nat. Med."}, {"key": "BFnrd4608_CR36", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1136/gutjnl-2011-300703", "volume": "62", "author": "J Ribera", "year": "2012", "unstructured": "Ribera, J. et al. Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut 62, 138\u2013145 (2012).", "journal-title": "Gut"}, {"key": "BFnrd4608_CR37", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.4103/0975-3583.85260", "volume": "2", "author": "D Jones", "year": "2011", "unstructured": "Jones, D. & Min, W. An overview of lymphatic vessels and their emerging role in cardiovascular disease. J. Cardiovasc. Dis. Res. 2, 141\u2013152 (2011).", "journal-title": "J. Cardiovasc. Dis. Res."}, {"key": "BFnrd4608_CR38", "doi-asserted-by": "crossref", "first-page": "2307", "DOI": "10.1073/pnas.1318249111", "volume": "111", "author": "CV Fletcher", "year": "2014", "unstructured": "Fletcher, C. V. et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl Acad. Sci. USA 111, 2307\u20132312 (2014). The data presented in this article links persistent HIV replication with low antiretroviral drug concentrations in lymphatic tissues in humans. Increasing drug distribution to lymph may therefore provide a treatment benefit.", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR39", "doi-asserted-by": "crossref", "first-page": "9838", "DOI": "10.1073/pnas.88.21.9838", "volume": "88", "author": "G Pantaleo", "year": "1991", "unstructured": "Pantaleo, G. et al. Lymphoid organs function as major reservoirs for human-immunodeficiency-virus. Proc. Natl Acad. Sci. USA 88, 9838\u20139842 (1991).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR40", "doi-asserted-by": "crossref", "first-page": "2943", "DOI": "10.1182/blood-2007-09-112490", "volume": "111", "author": "C Giannini", "year": "2008", "unstructured": "Giannini, C. et al. Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood 111, 2943\u20132945 (2008).", "journal-title": "Blood"}, {"key": "BFnrd4608_CR41", "doi-asserted-by": "crossref", "first-page": "e1000688", "DOI": "10.1371/journal.ppat.1000688", "volume": "5", "author": "S Bennuru", "year": "2009", "unstructured": "Bennuru, S. & Nutman, T. B. Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis. PLoS Pathog. 5, e1000688 (2009).", "journal-title": "PLoS Pathog."}, {"key": "BFnrd4608_CR42", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1016/S0140-6736(10)60667-8", "volume": "377", "author": "H Feldmann", "year": "2011", "unstructured": "Feldmann, H. & Geisbert, T. W. Ebola haemorrhagic fever. Lancet 377, 849\u2013862 (2011).", "journal-title": "Lancet"}, {"key": "BFnrd4608_CR43", "doi-asserted-by": "crossref", "first-page": "E103", "DOI": "10.1111/j.1749-6632.2010.05713.x", "volume": "1207", "author": "EA Deitch", "year": "2010", "unstructured": "Deitch, E. A. Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann. NY Acad. Sci. 1207, E103\u2013E111 (2010).", "journal-title": "Ann. NY Acad. Sci."}, {"key": "BFnrd4608_CR44", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1038/nm1340", "volume": "12", "author": "D Kerjaschki", "year": "2006", "unstructured": "Kerjaschki, D. et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 12, 230\u2013234 (2006).", "journal-title": "Nat. Med."}, {"key": "BFnrd4608_CR45", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1016/j.addr.2012.10.013", "volume": "65", "author": "X Wang", "year": "2013", "unstructured": "Wang, X. et al. Mechanism of oral tolerance induction to therapeutic proteins. Adv. Drug Deliv. Rev. 65, 759\u2013773 (2013).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR46", "doi-asserted-by": "crossref", "first-page": "148rv9", "DOI": "10.1126/scitranslmed.3003763", "volume": "4", "author": "MA Swartz", "year": "2012", "unstructured": "Swartz, M. A., Hirosue, S. & Hubbell, J. A. Engineering approaches to immunotherapy. Sci. Transl. Med. 4, 148rv9 (2012).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4608_CR47", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1016/j.addr.2007.09.007", "volume": "60", "author": "NL Trevaskis", "year": "2008", "unstructured": "Trevaskis, N. L., Charman, W. N. & Porter, C. J. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv. Drug Deliv. Rev. 60, 702\u2013716 (2008).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR48", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/j.jconrel.2014.04.051", "volume": "193", "author": "GM Ryan", "year": "2014", "unstructured": "Ryan, G. M., Kaminskas, L. M. & Porter, C. J. Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. J. Control. Release 193, 241\u2013256 (2014).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR49", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1016/j.addr.2011.05.019", "volume": "63", "author": "JA Y\u00e1\u00f1ez", "year": "2011", "unstructured": "Y\u00e1\u00f1ez, J. A., Wang, S. W. J., Knemeyer, I. W., Wirth, M. A. & Alton, K. B. Intestinal lymphatic transport for drug delivery. Adv. Drug Deliv. Rev. 63, 923\u2013942 (2011).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR50", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1023/A:1015880819328", "volume": "7", "author": "A Supersaxo", "year": "1990", "unstructured": "Supersaxo, A., Hein, W. R. & Steffen, H. Effect of molecular-weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm. Res. 7, 167\u2013169 (1990). The first paper to describe the relationship between molecular mass of proteins and lymphatic uptake from interstitial injection sites in sheep.", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR51", "doi-asserted-by": "crossref", "first-page": "978", "DOI": "10.1038/nmat3775", "volume": "12", "author": "DJ Irvine", "year": "2013", "unstructured": "Irvine, D. J., Swartz, M. A. & Szeto, G. L. Engineering synthetic vaccines using cues from natural immunity. Nat. Mater. 12, 978\u2013990 (2013).", "journal-title": "Nat. Mater."}, {"key": "BFnrd4608_CR52", "doi-asserted-by": "crossref", "first-page": "1620", "DOI": "10.1023/A:1013046918190", "volume": "18", "author": "SA Charman", "year": "2001", "unstructured": "Charman, S. A., McLennan, D. N., Edwards, G. A. & Porter, C. J. H. Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model. Pharm. Res. 18, 1620\u20131626 (2001).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR53", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1002/(SICI)1520-6017(200002)89:2<168::AID-JPS4>3.0.CO;2-Q", "volume": "89", "author": "SA Charman", "year": "2000", "unstructured": "Charman, S. A., Segrave, A. M., Edwards, G. A. & Porter, C. J. H. Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection. J. Pharm. Sci. 89, 168\u2013177 (2000).", "journal-title": "J. Pharm. Sci."}, {"key": "BFnrd4608_CR54", "doi-asserted-by": "crossref", "first-page": "2211", "DOI": "10.1124/dmd.107.015669", "volume": "35", "author": "J Kota", "year": "2007", "unstructured": "Kota, J. et al. Lymphatic absorption of subcutaneously administered proteins: influence of different injection sites on the absorption of darbepoetin alfa using a sheep model. Drug Metab. Dispos. 35, 2211\u20132217 (2007).", "journal-title": "Drug Metab. Dispos."}, {"key": "BFnrd4608_CR55", "doi-asserted-by": "crossref", "first-page": "1156", "DOI": "10.1023/A:1025036611949", "volume": "20", "author": "D McLennan", "year": "2003", "unstructured": "McLennan, D. et al. Pharmacokinetic model to describe the lymphatic absorption of r-methu-leptin after subcutaneous injection to sheep. Pharm. Res. 20, 1156\u20131162 (2003).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR56", "doi-asserted-by": "crossref", "first-page": "2060", "DOI": "10.1007/s11095-006-9064-8", "volume": "23", "author": "D McLennan", "year": "2006", "unstructured": "McLennan, D. et al. The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheep. Pharm. Res. 23, 2060\u20132066 (2006).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR57", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1124/jpet.104.078790", "volume": "313", "author": "DN McLennan", "year": "2005", "unstructured": "McLennan, D. N. et al. Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep. J. Pharmacol. Exp. Ther. 313, 345\u2013351 (2005).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BFnrd4608_CR58", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/S0005-2736(97)00122-3", "volume": "1328", "author": "C Oussoren", "year": "1997", "unstructured": "Oussoren, C., Zuidema, J., Crommelin, D. J. & Storm, G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim. Biophys. Acta 1328, 261\u2013272 (1997). The first paper to establish the influence of size and composition on lymphatic uptake and retention of model delivery systems (liposomes).", "journal-title": "Biochim. Biophys. Acta"}, {"key": "BFnrd4608_CR59", "doi-asserted-by": "crossref", "first-page": "1159", "DOI": "10.1038/nbt1332", "volume": "25", "author": "ST Reddy", "year": "2007", "unstructured": "Reddy, S. T. et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotech. 25, 1159\u20131164 (2007).", "journal-title": "Nat. Biotech."}, {"key": "BFnrd4608_CR60", "doi-asserted-by": "crossref", "first-page": "3271", "DOI": "10.1007/s11095-013-1218-x", "volume": "30", "author": "AL Reed", "year": "2013", "unstructured": "Reed, A. L., Rowson, S. A. & Dixon, J. B. Demonstration of ATP-dependent, transcellular transport of lipid across the lymphatic endothelium using an in vitro model of the lacteal. Pharm. Res. 30, 3271\u20133280 (2013).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR61", "doi-asserted-by": "crossref", "first-page": "9381", "DOI": "10.1073/pnas.0403317101", "volume": "101", "author": "P Laakkonen", "year": "2004", "unstructured": "Laakkonen, P. et al. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc. Natl Acad. Sci. USA 101, 9381\u20139386 (2004).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR62", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1038/nm720", "volume": "8", "author": "P Laakkonen", "year": "2002", "unstructured": "Laakkonen, P., Porkka, K., Hoffman, J. A. & Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8, 751\u2013755 (2002).", "journal-title": "Nat. Med."}, {"key": "BFnrd4608_CR63", "doi-asserted-by": "crossref", "first-page": "1128", "DOI": "10.1152/jappl.1985.59.4.1128", "volume": "59", "author": "JC Parker", "year": "1985", "unstructured": "Parker, J. C., Gilchrist, S. & Cartledge, J. T. Plasma\u2013lymph exchange and interstitial distribution volumes of charged macromolecules in the lung. J. Appl. Physiol. 59, 1128\u20131136 (1985).", "journal-title": "J. Appl. Physiol."}, {"key": "BFnrd4608_CR64", "doi-asserted-by": "crossref", "first-page": "1342", "DOI": "10.1016/j.bpj.2010.06.016", "volume": "99", "author": "T Stylianopoulos", "year": "2010", "unstructured": "Stylianopoulos, T. et al. Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. Biophys. J. 99, 1342\u20131349 (2010).", "journal-title": "Biophys. J."}, {"key": "BFnrd4608_CR65", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1016/j.jconrel.2009.08.005", "volume": "140", "author": "LM Kaminskas", "year": "2009", "unstructured": "Kaminskas, L. M. et al. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats. J. Control. Release 140, 108\u2013116 (2009). This article shows that PEGylation of the therapeutic protein interferon-\u03b12 increases lymphatic distribution and ultimately increases therapeutic efficacy against a lymph-resident cancer.", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR66", "doi-asserted-by": "crossref", "first-page": "2018", "DOI": "10.1002/jps.21970", "volume": "99", "author": "DA Rao", "year": "2010", "unstructured": "Rao, D. A., Forrest, M. L., Alani, A. W., Kwon, G. S. & Robinson, J. R. Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. J. Pharm. Sci. 99, 2018\u20132031 (2010).", "journal-title": "J. Pharm. Sci."}, {"key": "BFnrd4608_CR67", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1007/s11095-010-0123-9", "volume": "28", "author": "AJ Harvey", "year": "2011", "unstructured": "Harvey, A. J. et al. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm. Res. 28, 107\u2013116 (2011).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR68", "doi-asserted-by": "crossref", "first-page": "3197", "DOI": "10.1016/j.vaccine.2008.03.095", "volume": "26", "author": "PH Lambert", "year": "2008", "unstructured": "Lambert, P. H. & Laurent, P. E. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26, 3197\u20133208 (2008).", "journal-title": "Vaccine"}, {"key": "BFnrd4608_CR69", "doi-asserted-by": "crossref", "first-page": "1201", "DOI": "10.1586/14760584.7.8.1201", "volume": "7", "author": "J-F Nicolas", "year": "2008", "unstructured": "Nicolas, J.-F. & Guy, B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev. Vaccines 7, 1201\u20131214 (2008).", "journal-title": "Expert Rev. Vaccines"}, {"key": "BFnrd4608_CR70", "first-page": "390", "volume": "7", "author": "V Bocci", "year": "1988", "unstructured": "Bocci, V., Pessina, G. P., Paulesu, L. & Nicoletti, C. The lymphatic route. VI. Distribution of recombinant interferon-\u03b12 in rabbit and pig plasma and lymph. J. Biolog. Response Mod. 7, 390\u2013400 (1988).", "journal-title": "J. Biolog. Response Mod."}, {"key": "BFnrd4608_CR71", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.3109/10611860903318126", "volume": "18", "author": "L Feng", "year": "2010", "unstructured": "Feng, L. et al. Roles of dextrans on improving lymphatic drainage for liposomal drug delivery system. J. Drug Target. 18, 168\u2013178 (2010).", "journal-title": "J. Drug Target."}, {"key": "BFnrd4608_CR72", "first-page": "243", "volume": "42", "author": "GP Pessina", "year": "1993", "unstructured": "Pessina, G. P., Bocci, V., Carraro, F., Naldini, A. & Paulesu, L. The lymphatic route. IX. Distribution of recombinant interferon-\u03b1 2 administered subcutaneously with oedematogenic drugs. Physiol. Res. 42, 243\u2013250 (1993).", "journal-title": "Physiol. Res."}, {"key": "BFnrd4608_CR73", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1038/nature12978", "volume": "507", "author": "H Liu", "year": "2014", "unstructured": "Liu, H. et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature 507, 519\u2013522 (2014). A pioneering article that uses targeted delivery to the lymphatics to enhance vaccination. This was achieved by the conjugation of peptides to lipids that bind to albumin and 'hitchhike' onto transport pathways from the interstitium into the lymphatics.", "journal-title": "Nature"}, {"key": "BFnrd4608_CR74", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1002/bip.20978", "volume": "89", "author": "G Jiang", "year": "2008", "unstructured": "Jiang, G. et al. Hyaluronic acid\u2013polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 89, 635\u2013642 (2008).", "journal-title": "Biopolymers"}, {"key": "BFnrd4608_CR75", "doi-asserted-by": "crossref", "first-page": "7210", "DOI": "10.1158/0008-5472.CAN-07-6752", "volume": "68", "author": "V Fogal", "year": "2008", "unstructured": "Fogal, V., Zhang, L., Krajewski, S. & Ruoslahti, E. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res. 68, 7210\u20137218 (2008).", "journal-title": "Cancer Res."}, {"key": "BFnrd4608_CR76", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/j.nano.2008.07.007", "volume": "5", "author": "PP Karmali", "year": "2009", "unstructured": "Karmali, P. P. et al. Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine 5, 73\u201382 (2009).", "journal-title": "Nanomedicine"}, {"key": "BFnrd4608_CR77", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1016/j.ijpharm.2009.10.014", "volume": "385", "author": "G Luo", "year": "2010", "unstructured": "Luo, G. et al. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Int. J. Pharm. 385, 150\u2013156 (2010).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR78", "doi-asserted-by": "crossref", "first-page": "118", "DOI": "10.1016/j.jconrel.2011.07.034", "volume": "157", "author": "Z Yan", "year": "2012", "unstructured": "Yan, Z. et al. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. J. Control. Release 157, 118\u2013125 (2012).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR79", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1038/nrc2748", "volume": "10", "author": "JS Desgrosellier", "year": "2010", "unstructured": "Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9\u201322 (2010).", "journal-title": "Nat. Rev. Cancer"}, {"key": "BFnrd4608_CR80", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1208/s12248-014-9708-2", "volume": "17", "author": "J Andorko", "year": "2014", "unstructured": "Andorko, J., Hess, K. & Jewell, C. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance. AAPS J. 17, 323\u2013338 (2014). A summary of the mechanisms by which materials can be engineered to promote delivery to cells within the lymphatics to enhance vaccination and tolerance induction.", "journal-title": "AAPS J."}, {"key": "BFnrd4608_CR81", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.jconrel.2014.12.024", "volume": "200", "author": "Q Zeng", "year": "2015", "unstructured": "Zeng, Q. et al. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses. J. Control. Release 200, 1\u201312 (2015).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR82", "doi-asserted-by": "crossref", "first-page": "5475", "DOI": "10.1016/j.vaccine.2014.07.081", "volume": "32", "author": "C Wang", "year": "2014", "unstructured": "Wang, C. et al. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory. Vaccine 32, 5475\u20135483 (2014).", "journal-title": "Vaccine"}, {"key": "BFnrd4608_CR83", "first-page": "1000003", "volume": "1", "author": "AK Azad", "year": "2014", "unstructured": "Azad, A. K., Rajaram, M. V. & Schlesinger, L. S. Exploitation of the macrophage mannose receptor (CD206) in infectious disease diagnostics and therapeutics. J. Cytol. Mol. Biol. 1, 1000003 (2014).", "journal-title": "J. Cytol. Mol. Biol."}, {"key": "BFnrd4608_CR84", "doi-asserted-by": "crossref", "first-page": "18264", "DOI": "10.1073/pnas.0509541102", "volume": "102", "author": "YJ Kwon", "year": "2005", "unstructured": "Kwon, Y. J., James, E., Shastri, N. & Fr\u00e9chet, J. M. J. In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc. Natl Acad. Sci. USA 102, 18264\u201318268 (2005).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR85", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1021/mp400464s", "volume": "11", "author": "AM Dahlberg", "year": "2014", "unstructured": "Dahlberg, A. M. et al. The lymphatic system plays a major role in the intravenous and subcutaneous pharmacokinetics of trastuzumab in rats. Mol. Pharm. 11, 496\u2013504 (2014).", "journal-title": "Mol. Pharm."}, {"key": "BFnrd4608_CR86", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1016/j.jconrel.2013.08.004", "volume": "172", "author": "GM Ryan", "year": "2013", "unstructured": "Ryan, G. M. et al. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin. J. Control. Release 172, 128\u2013136 (2013).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR87", "doi-asserted-by": "crossref", "first-page": "4688", "DOI": "10.1016/j.biomaterials.2014.02.030", "volume": "35", "author": "YC Tseng", "year": "2014", "unstructured": "Tseng, Y. C., Xu, Z., Guley, K., Yuan, H. & Huang, L. Lipid\u2013calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases. Biomaterials 35, 4688\u20134698 (2014).", "journal-title": "Biomaterials"}, {"key": "BFnrd4608_CR88", "doi-asserted-by": "crossref", "first-page": "1299", "DOI": "10.1172/JCI67677", "volume": "123", "author": "JJ Iliff", "year": "2013", "unstructured": "Iliff, J. J. et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J. Clin. Invest. 123, 1299\u20131309 (2013).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR89", "doi-asserted-by": "crossref", "first-page": "147ra111", "DOI": "10.1126/scitranslmed.3003748", "volume": "4", "author": "JJ Iliff", "year": "2012", "unstructured": "Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci. Transl. Med. 4, 147ra111 (2012). This article provides the first description of the glymphatic system \u2014 a brain-wide paravascular pathway for CSF and ISF exchange that facilitates the clearance of solutes and waste from the brain.", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4608_CR90", "doi-asserted-by": "crossref", "first-page": "18190", "DOI": "10.1523/JNEUROSCI.1592-13.2013", "volume": "33", "author": "JJ Iliff", "year": "2013", "unstructured": "Iliff, J. J. et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J. Neurosci. 33, 18190\u201318199 (2013).", "journal-title": "J. Neurosci."}, {"key": "BFnrd4608_CR91", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1126/science.1241224", "volume": "342", "author": "L Xie", "year": "2013", "unstructured": "Xie, L. et al. Sleep drives metabolite clearance from the adult brain. Science 342, 373\u2013377 (2013).", "journal-title": "Science"}, {"key": "BFnrd4608_CR92", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1186/1479-5876-11-107", "volume": "11", "author": "L Yang", "year": "2013", "unstructured": "Yang, L. et al. Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J. Transl. Med. 11, 107 (2013).", "journal-title": "J. Transl. Med."}, {"key": "BFnrd4608_CR93", "doi-asserted-by": "crossref", "first-page": "991", "DOI": "10.1084/jem.20142290", "volume": "212", "author": "A Aspelund", "year": "2015", "unstructured": "Aspelund, A., et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991\u2013999 (2015).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4608_CR94", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1038/nature14432", "volume": "523", "author": "A Louveau", "year": "2015", "unstructured": "Louveau, A., et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337\u2013341 (2015).", "journal-title": "Nature"}, {"key": "BFnrd4608_CR95", "author": "D Shackleford", "first-page": "653", "year": "2007", "unstructured": "Shackleford, D., Porter, C. H. & Charman, W. in Prodrugs Vol. 5 (eds Stella, V. et al.) 653\u2013682 (Springer, 2007).", "volume-title": "Prodrugs", "DOI": "10.1007/978-0-387-49785-3_18", "doi-asserted-by": "crossref"}, {"issue": "Suppl. 2", "key": "BFnrd4608_CR96", "doi-asserted-by": "crossref", "first-page": "S15", "DOI": "10.1016/S0928-0987(00)00161-5", "volume": "11", "author": "DM Lambert", "year": "2000", "unstructured": "Lambert, D. M. Rationale and applications of lipids as prodrug carriers. Eur. J. Pharm. Sci. 11 (Suppl. 2), S15\u2013S27 (2000).", "journal-title": "Eur. J. Pharm. Sci."}, {"key": "BFnrd4608_CR97", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1016/j.addr.2011.07.003", "volume": "64", "author": "J Kunisawa", "year": "2012", "unstructured": "Kunisawa, J., Kurashima, Y. & Kiyono, H. Gut-associated lymphoid tissues for the development of oral vaccines. Adv. Drug Deliv. Rev. 64, 523\u2013530 (2012).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR98", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.1016/j.addr.2013.04.006", "volume": "65", "author": "SH Bakhru", "year": "2013", "unstructured": "Bakhru, S. H., Furtado, S., Morello, A. P. & Mathiowitz, E. Oral delivery of proteins by biodegradable nanoparticles. Adv. Drug Deliv. Rev. 65, 811\u2013821 (2013).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR99", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.ddtec.2005.05.019", "volume": "2", "author": "AT Florence", "year": "2005", "unstructured": "Florence, A. T. Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discov. Today Technol. 2, 75\u201381 (2005).", "journal-title": "Drug Discov. Today Technol."}, {"key": "BFnrd4608_CR100", "doi-asserted-by": "crossref", "first-page": "1460", "DOI": "10.1023/A:1025718513246", "volume": "20", "author": "SM Khoo", "year": "2003", "unstructured": "Khoo, S. M., Shackleford, D. M., Porter, C. J., Edwards, G. A. & Charman, W. N. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm. Res. 20, 1460\u20131465 (2003). This article uses a dog model to demonstrate the potential for even a single capsule of lipid to promote significant intestinal lymphatic drug transport.", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR101", "doi-asserted-by": "crossref", "first-page": "1073", "DOI": "10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V", "volume": "89", "author": "SM Caliph", "year": "2000", "unstructured": "Caliph, S. M., Charman, W. N. & Porter, C. J. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci. 89, 1073\u20131084 (2000).", "journal-title": "J. Pharm. Sci."}, {"key": "BFnrd4608_CR102", "doi-asserted-by": "crossref", "first-page": "3254", "DOI": "10.1007/s11095-013-1000-0", "volume": "30", "author": "NL Trevaskis", "year": "2013", "unstructured": "Trevaskis, N. L. et al. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport. Pharm. Res. 30, 3254\u20133270 (2013). An article describing a mesenteric lymph duct cannulated mouse model to evaluate intestinal lymphatic drug transport and provides a cross comparison of preclinical species.", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR103", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1016/0378-5173(86)90027-X", "volume": "34", "author": "WN Charman", "year": "1986", "unstructured": "Charman, W. N. & Stella, V. J. Estimating the maximum potential for intestinal lymphatic transport of lipophilic drug molecules. Int. J. Pharm. 34, 175\u2013178 (1986). The first paper to suggest the importance of logP and lipid solubility in indicating the potential for drug absorption via the intestinal lymphatics.", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR104", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1016/0378-5173(92)90261-Y", "volume": "80", "author": "RA Myers", "year": "1992", "unstructured": "Myers, R. A. & Stella, V. J. Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug \u2014 comparison to DDT and hexachlorobenzene. Int. J. Pharm. 80, 51\u201362 (1992).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR105", "doi-asserted-by": "crossref", "first-page": "1949", "DOI": "10.1007/s11095-010-0199-2", "volume": "27", "author": "NL Trevaskis", "year": "2010", "unstructured": "Trevaskis, N. L., Shanker, R. M., Charman, W. N. & Porter, C. J. The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles. Pharm. Res. 27, 1949\u20131964 (2010).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR106", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1124/dmd.113.055053", "volume": "42", "author": "EF Choo", "year": "2014", "unstructured": "Choo, E. F. et al. The role of lymphatic transport on the systemic bioavailability of the Bcl-2 protein family inhibitors navitoclax (ABT-263) and ABT-199. Drug Metab. Dispos. 42, 207\u2013212 (2014). This article demonstrates significant intestinal lymphatic transport of a clinical drug candidate in dogs.", "journal-title": "Drug Metab. Dispos."}, {"key": "BFnrd4608_CR107", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1211/jpp.61.01.0005", "volume": "61", "author": "P Gershkovich", "year": "2009", "unstructured": "Gershkovich, P. et al. The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons. J. Pharm. Pharmacol. 61, 31\u201339 (2009).", "journal-title": "J. Pharm. Pharmacol."}, {"key": "BFnrd4608_CR108", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1016/j.ejps.2005.07.011", "volume": "26", "author": "P Gershkovich", "year": "2005", "unstructured": "Gershkovich, P. & Hoffman, A. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability. Eur. J. Pharm. Sci. 26, 394\u2013404 (2005).", "journal-title": "Eur. J. Pharm. Sci."}, {"key": "BFnrd4608_CR109", "doi-asserted-by": "crossref", "first-page": "1817", "DOI": "10.1007/s11095-014-1578-x", "volume": "32", "author": "E Lawless", "year": "2014", "unstructured": "Lawless, E., Griffin, B., O'Mahony, A. & O'Driscoll, C. Exploring the impact of drug properties on the extent of intestinal lymphatic transport \u2014 in vitro and in vivo studies. Pharm. Res. 32, 1817\u20131829 (2014).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR110", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/j.ijpharm.2015.02.017", "volume": "483", "author": "Y Lu", "year": "2015", "unstructured": "Lu, Y. et al. Biomimetic reassembled chylomicrons as novel association model for the prediction of lymphatic transportation of highly lipophilic drugs via the oral route. Int. J. Pharm. 483, 69\u201376 (2015).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR111", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1016/j.ijpharm.2003.12.017", "volume": "272", "author": "R Holm", "year": "2004", "unstructured": "Holm, R. & Hoest, J. Successful in silico predicting of intestinal lymphatic transfer. Int. J. Pharm. 272, 189\u2013193 (2004).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR112", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/S0169-409X(00)00129-0", "volume": "46", "author": "CA Lipinski", "year": "2001", "unstructured": "Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3\u201326 (2001).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR113", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1038/nrd4163", "volume": "13", "author": "AL Hopkins", "year": "2014", "unstructured": "Hopkins, A. L., Keseru, G. M., Leeson, P. D., Rees, D. C. & Reynolds, C. H. The role of ligand efficiency metrics in drug discovery. Nat. Rev. Drug Discov. 13, 105\u2013121 (2014).", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "BFnrd4608_CR114", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.jconrel.2013.12.031", "volume": "177", "author": "S Han", "year": "2014", "unstructured": "Han, S. et al. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies. J. Control. Release 177, 1\u201310 (2014). This article reports glyceride mimetic prodrugs that are more efficiently transported into the intestinal lymph following oral delivery compared with alkyl ester or amide prodrugs, and that they enhance drug delivery to MLNs.", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR115", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1248/bpb1978.11.369", "volume": "11", "author": "J Sugihara", "year": "1988", "unstructured": "Sugihara, J., Furuuchi, S., Nakano, K. & Harigaya, S. Studies on intestinal lymphatic absorption of drugs. I. Lymphatic absorption of alkyl ester derivatives and alpha-monoglyceride derivatives of drugs. J. Pharmacobiodyn. 11, 369\u2013376 (1988).", "journal-title": "J. Pharmacobiodyn."}, {"key": "BFnrd4608_CR116", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1248/bpb1978.11.555", "volume": "11", "author": "J Sugihara", "year": "1988", "unstructured": "Sugihara, J., Furuuchi, S., Ando, H., Takashima, K. & Harigaya, S. Studies on intestinal lymphatic absorption of drugs. II. Glyceride prodrugs for improving lymphatic absorption of naproxen and nicotinic-acid. J. Pharmacobiodyn. 11, 555\u2013562 (1988).", "journal-title": "J. Pharmacobiodyn."}, {"key": "BFnrd4608_CR117", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.jconrel.2007.10.025", "volume": "126", "author": "A Dahan", "year": "2008", "unstructured": "Dahan, A. et al. The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin\u2013valproic acid conjugate following oral administration. J. Control. Release 126, 1\u20139 (2008).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR118", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1002/jps.2600820606", "volume": "82", "author": "A Sakai", "year": "1993", "unstructured": "Sakai, A., Mori, N., Shuto, S. & Suzuki, T. Deacylation-reacylation cycle: a possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoylphosphatidylfluorouridine in rats. J. Pharm. Sci. 82, 575\u2013578 (1993).", "journal-title": "J. Pharm. Sci."}, {"key": "BFnrd4608_CR119", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S0169-409X(01)00152-1", "volume": "50", "author": "N Hussain", "year": "2001", "unstructured": "Hussain, N., Jaitley, V. & Florence, A. T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. 50, 107\u2013142 (2001).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR120", "doi-asserted-by": "crossref", "first-page": "822", "DOI": "10.1016/j.addr.2012.10.007", "volume": "65", "author": "Y Yun", "year": "2013", "unstructured": "Yun, Y., Cho, Y. W. & Park, K. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv. Drug Deliv. Rev. 65, 822\u2013832 (2013).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR121", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1111/j.1600-065X.2010.00970.x", "volume": "239", "author": "MF Pasetti", "year": "2011", "unstructured": "Pasetti, M. F., Simon, J. K., Sztein, M. B. & Levine, M. M. Immunology of gut mucosal vaccines. Immunol. Rev. 239, 125\u2013148 (2011).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4608_CR122", "doi-asserted-by": "crossref", "first-page": "17498", "DOI": "10.1073/pnas.1313839110", "volume": "110", "author": "S Attili-Qadri", "year": "2013", "unstructured": "Attili-Qadri, S. et al. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc. Natl Acad. Sci. USA 110, 17498\u201317503 (2013).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR123", "doi-asserted-by": "crossref", "first-page": "213ra167", "DOI": "10.1126/scitranslmed.3007049", "volume": "5", "author": "EM Pridgen", "year": "2013", "unstructured": "Pridgen, E. M. et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery. Sci. Transl. Med. 5, 213ra167 (2013).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4608_CR124", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1038/nri1777", "volume": "6", "author": "MR Neutra", "year": "2006", "unstructured": "Neutra, M. R. & Kozlowski, P. A. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6, 148\u2013158 (2006).", "journal-title": "Nat. Rev. Immunol."}, {"key": "BFnrd4608_CR125", "doi-asserted-by": "crossref", "first-page": "3101", "DOI": "10.1084/jem.20091925", "volume": "206", "author": "O Schulz", "year": "2009", "unstructured": "Schulz, O. et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J. Exp. Med. 206, 3101\u20133114 (2009).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4608_CR126", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/B978-0-12-381300-8.00004-6", "volume": "107", "author": "M Rescigno", "year": "2010", "unstructured": "Rescigno, M. Intestinal dendritic cells. Adv. Immunol. 107, 109\u2013138 (2010).", "journal-title": "Adv. Immunol."}, {"key": "BFnrd4608_CR127", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1126/science.1102901", "volume": "307", "author": "JH Niess", "year": "2005", "unstructured": "Niess, J. H. et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254\u2013258 (2005).", "journal-title": "Science"}, {"key": "BFnrd4608_CR128", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/S0169-409X(00)00070-3", "volume": "43", "author": "MA Clark", "year": "2000", "unstructured": "Clark, M. A., Hirst, B. H. & Jepson, M. A. Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 43, 207\u2013223 (2000).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR129", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1023/A:1011981610840", "volume": "15", "author": "N Hussain", "year": "1998", "unstructured": "Hussain, N. & Florence, A. Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm. Res. 15, 153\u2013156 (1998).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR130", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1016/j.ejpb.2009.04.009", "volume": "73", "author": "V Fievez", "year": "2009", "unstructured": "Fievez, V. et al. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur. J. Pharm. Biopharm. 73, 16\u201324 (2009).", "journal-title": "Eur. J. Pharm. Biopharm."}, {"key": "BFnrd4608_CR131", "doi-asserted-by": "crossref", "first-page": "1573", "DOI": "10.1016/j.biomaterials.2011.10.075", "volume": "33", "author": "Y Jin", "year": "2012", "unstructured": "Jin, Y. et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 33, 1573\u20131582 (2012).", "journal-title": "Biomaterials"}, {"key": "BFnrd4608_CR132", "doi-asserted-by": "crossref", "first-page": "13803", "DOI": "10.1073/pnas.1305882110", "volume": "110", "author": "JJ Reineke", "year": "2013", "unstructured": "Reineke, J. J. et al. Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres. Proc. Natl Acad. Sci. USA 110, 13803\u201313808 (2013).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR133", "doi-asserted-by": "crossref", "first-page": "1838", "DOI": "10.1023/A:1016085108889", "volume": "13", "author": "MP Desai", "year": "1996", "unstructured": "Desai, M. P., Labhasetwar, V., Amidon, G. L. & Levy, R. J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13, 1838\u20131845 (1996).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR134", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1111/j.2042-7158.1990.tb07033.x", "volume": "42", "author": "P Jani", "year": "1990", "unstructured": "Jani, P., Halbert, G. W., Langridge, J. & Florence, A. T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42, 821\u2013826 (1990).", "journal-title": "J. Pharm. Pharmacol."}, {"key": "BFnrd4608_CR135", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1023/A:1015964916486", "volume": "7", "author": "JA Ebel", "year": "1990", "unstructured": "Ebel, J. A. Method for quantifying particle absorption from the small intestine of the mouse. Pharm. Res. 7, 848\u2013851 (1990).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR136", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/0378-5173(94)90064-7", "volume": "102", "author": "PG Jenkins", "year": "1994", "unstructured": "Jenkins, P. G. et al. The quantitation of the absorption of microparticles into the intestinal lymph of Wistar rats. Int. J. Pharm. 102, 261\u2013266 (1994).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR137", "doi-asserted-by": "crossref", "first-page": "522", "DOI": "10.3181/00379727-179-42133", "volume": "179", "author": "ME Lefevre", "year": "1985", "unstructured": "Lefevre, M. E., Joel, D. D. & Schidlovsky, G. Retention of ingested latex particles in Peyer's patches of germfree and conventional mice. Proc. Soc. Exp. Biol. Med. 179, 522\u2013528 (1985).", "journal-title": "Proc. Soc. Exp. Biol. Med."}, {"key": "BFnrd4608_CR138", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1023/A:1012153011884", "volume": "14", "author": "N Hussain", "year": "1997", "unstructured": "Hussain, N., Jani, P. U. & Florence, A. T. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm. Res. 14, 613\u2013618 (1997).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR139", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/j.jconrel.2014.07.060", "volume": "194", "author": "B Ralay-Ranaivo", "year": "2014", "unstructured": "Ralay-Ranaivo, B. et al. Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation. J. Control. Release 194, 323\u2013331 (2014).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR140", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/j.ijpharm.2006.07.026", "volume": "327", "author": "N Zhang", "year": "2006", "unstructured": "Zhang, N. et al. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int. J. Pharm. 327, 153\u2013159 (2006).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR141", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1016/S0168-3659(99)00237-0", "volume": "65", "author": "AT Florence", "year": "2000", "unstructured": "Florence, A. T., Sakthivel, T. & Toth, I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J. Control. Release 65, 253\u2013259 (2000).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR142", "doi-asserted-by": "crossref", "first-page": "2986", "DOI": "10.1021/mp400091n", "volume": "10", "author": "GM Ryan", "year": "2013", "unstructured": "Ryan, G. M. et al. Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent. Mol. Pharm. 10, 2986\u20132995 (2013).", "journal-title": "Mol. Pharm."}, {"key": "BFnrd4608_CR143", "doi-asserted-by": "crossref", "first-page": "592", "DOI": "10.1038/nri3251", "volume": "12", "author": "N Lycke", "year": "2012", "unstructured": "Lycke, N. Recent progress in mucosal vaccine development: potential and limitations. Nat. Rev. Immunol. 12, 592\u2013605 (2012).", "journal-title": "Nat. Rev. Immunol."}, {"key": "BFnrd4608_CR144", "doi-asserted-by": "crossref", "first-page": "8506", "DOI": "10.1016/j.vaccine.2011.09.010", "volume": "29", "author": "EN Meeusen", "year": "2011", "unstructured": "Meeusen, E. N. Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 29, 8506\u20138511 (2011).", "journal-title": "Vaccine"}, {"key": "BFnrd4608_CR145", "doi-asserted-by": "crossref", "first-page": "804", "DOI": "10.1016/j.vaccine.2010.11.010", "volume": "29", "author": "A Stano", "year": "2011", "unstructured": "Stano, A. et al. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine 29, 804\u2013812 (2011).", "journal-title": "Vaccine"}, {"key": "BFnrd4608_CR146", "doi-asserted-by": "crossref", "first-page": "7541", "DOI": "10.1016/j.vaccine.2012.10.050", "volume": "30", "author": "A Stano", "year": "2012", "unstructured": "Stano, A., Nembrini, C., Swartz, M. A., Hubbell, J. A. & Simeoni, E. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization. Vaccine 30, 7541\u20137546 (2012).", "journal-title": "Vaccine"}, {"key": "BFnrd4608_CR147", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1517/17425247.5.6.629", "volume": "5", "author": "E Rytting", "year": "2008", "unstructured": "Rytting, E., Nguyen, J., Wang, X. & Kissel, T. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin. Drug Deliv. 5, 629\u2013639 (2008).", "journal-title": "Expert Opin. Drug Deliv."}, {"key": "BFnrd4608_CR148", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1513/pats.200409-049TA", "volume": "1", "author": "JS Patton", "year": "2004", "unstructured": "Patton, J. S., Fishburn, C. S. & Weers, J. G. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1, 338\u2013344 (2004).", "journal-title": "Proc. Am. Thorac. Soc."}, {"key": "BFnrd4608_CR149", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1016/j.pathophys.2009.10.008", "volume": "17", "author": "DE Schraufnagel", "year": "2010", "unstructured": "Schraufnagel, D. E. Lung lymphatic anatomy and correlates. Pathophysiology 17, 337\u2013343 (2010).", "journal-title": "Pathophysiology"}, {"key": "BFnrd4608_CR150", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1165/rcmb.2010-0152RT", "volume": "43", "author": "R Pabst", "year": "2010", "unstructured": "Pabst, R. & Tschernig, T. Bronchus-associated lymphoid tissue. Am. J. Respir. Cell. Mol. Biol. 43, 137\u2013141 (2010).", "journal-title": "Am. J. Respir. Cell. Mol. Biol."}, {"key": "BFnrd4608_CR151", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1089/jamp.2009.0797", "volume": "23", "author": "M Geiser", "year": "2010", "unstructured": "Geiser, M. Update on macrophage clearance of inhaled micro- and nanoparticles. J. Aerosol Med. Pulm. Drug Deliv. 23, 207\u2013217 (2010).", "journal-title": "J. Aerosol Med. Pulm. Drug Deliv."}, {"key": "BFnrd4608_CR152", "doi-asserted-by": "crossref", "first-page": "1868", "DOI": "10.1164/ajrccm.154.6.8970383", "volume": "154", "author": "A Wanner", "year": "1996", "unstructured": "Wanner, A., Salathe, M. & O'Riordan, T. G. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med. 154, 1868\u20131902 (1996).", "journal-title": "Am. J. Respir. Crit. Care Med."}, {"key": "BFnrd4608_CR153", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1369/jhc.2009.953067", "volume": "57", "author": "M Kambouchner", "year": "2009", "unstructured": "Kambouchner, M. & Bernaudin, J. F. Intralobular pulmonary lymphatic distribution in normal human lung using D2-40 antipodoplanin immunostaining. J. Histochem. Cytochem. 57, 643\u2013648 (2009).", "journal-title": "J. Histochem. Cytochem."}, {"key": "BFnrd4608_CR154", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/j.rppneu.2011.03.003", "volume": "17", "author": "MF Botelho", "year": "2011", "unstructured": "Botelho, M. F. et al. Visualization of deep lung lymphatic network using radioliposomes. Rev. Port. Pneumol. 17, 124\u2013130 (in Portuguese) (2011).", "journal-title": "Rev. Port. Pneumol."}, {"key": "BFnrd4608_CR155", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.3109/10611869509015955", "volume": "3", "author": "K Hanatani", "year": "1995", "unstructured": "Hanatani, K. et al. Molecular weight-dependent lymphatic transfer of fluorescein isothiocyanate-labeled dextrans after intrapulmonary administration and effects of various absorption enhancers on the lymphatic transfer of drugs in rats. J. Drug Target 3, 263\u2013271 (1995).", "journal-title": "J. Drug Target"}, {"key": "BFnrd4608_CR156", "doi-asserted-by": "crossref", "first-page": "1300", "DOI": "10.1038/nbt.1696", "volume": "28", "author": "HS Choi", "year": "2010", "unstructured": "Choi, H. S. et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotech. 28, 1300\u20131303 (2010).", "journal-title": "Nat. Biotech."}, {"key": "BFnrd4608_CR157", "first-page": "204ra130", "volume": "5", "author": "AV Li", "year": "2013", "unstructured": "Li, A. V. et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci. Transl. Med. 5, 204ra130 (2013).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4608_CR158", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1080/1061186021000054933", "volume": "10", "author": "MA Videira", "year": "2002", "unstructured": "Videira, M. A. et al. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target 10, 607\u2013613 (2002).", "journal-title": "J. Drug Target"}, {"key": "BFnrd4608_CR159", "doi-asserted-by": "crossref", "first-page": "1244", "DOI": "10.3181/0901-RM-8", "volume": "234", "author": "P Latimer", "year": "2009", "unstructured": "Latimer, P. et al. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp. Biol. Med. (Maywood) 234, 1244\u20131252 (2009).", "journal-title": "Exp. Biol. Med. (Maywood)"}, {"key": "BFnrd4608_CR160", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1007/s11095-012-0884-4", "volume": "30", "author": "AK Mohammad", "year": "2013", "unstructured": "Mohammad, A. K., Amayreh, L. K., Mazzara, J. M. & Reineke, J. J. Rapid lymph accumulation of polystyrene nanoparticles following pulmonary administration. Pharm. Res. 30, 424\u2013434 (2013).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR161", "doi-asserted-by": "crossref", "first-page": "801", "DOI": "10.1084/jem.171.3.801", "volume": "171", "author": "CR Mackay", "year": "1990", "unstructured": "Mackay, C. R., Marston, W. L. & Dudler, L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171, 801\u2013817 (1990).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4608_CR162", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.1038/ni.2085", "volume": "12", "author": "A Braun", "year": "2011", "unstructured": "Braun, A. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 12, 879\u2013887 (2011).", "journal-title": "Nat. Immunol."}, {"key": "BFnrd4608_CR163", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/S0169-409X(98)00099-4", "volume": "37", "author": "SM Moghimi", "year": "1999", "unstructured": "Moghimi, S. M. & Bonnemain, B. Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. Adv. Drug Deliv. Rev. 37, 295\u2013312 (1999).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR164", "doi-asserted-by": "crossref", "first-page": "963", "DOI": "10.1124/jpet.108.148163", "volume": "328", "author": "S-C Sensken", "year": "2009", "unstructured": "Sensken, S.-C., Bode, C. & Gr\u00e4ler, M. H. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy. J. Pharmacol. Exp. Ther. 328, 963\u2013969 (2009).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BFnrd4608_CR165", "doi-asserted-by": "crossref", "first-page": "1404", "DOI": "10.1002/eji.200737984", "volume": "38", "author": "V Manolova", "year": "2008", "unstructured": "Manolova, V. et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404\u20131413 (2008). The first demonstration of the relative importance of direct drainage versus transport after cellular uptake compared to lymph node uptake of particles after interstitial injection.", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4608_CR166", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/0014-5793(94)00351-3", "volume": "344", "author": "SM Moghimi", "year": "1994", "unstructured": "Moghimi, S. M. et al. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett. 344, 25\u201330 (1994).", "journal-title": "FEBS Lett."}, {"key": "BFnrd4608_CR167", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1016/S0005-2736(97)00275-7", "volume": "1370", "author": "C Oussoren", "year": "1998", "unstructured": "Oussoren, C. et al. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes. Biochim. Biophys. Acta 1370, 259\u2013272 (1998).", "journal-title": "Biochim. Biophys. Acta"}, {"key": "BFnrd4608_CR168", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/j.jconrel.2006.01.006", "volume": "112", "author": "ST Reddy", "year": "2006", "unstructured": "Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A. & Swartz, M. A. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J. Control. Release 112, 26\u201334 (2006). An article demonstrating the size dependency of lymphatic uptake, lymph node retention and lymph node dendritic cell uptake of nanoparticles.", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR169", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/j.immuni.2004.11.013", "volume": "22", "author": "M Sixt", "year": "2005", "unstructured": "Sixt, M. et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22, 19\u201329 (2005).", "journal-title": "Immunity"}, {"key": "BFnrd4608_CR170", "doi-asserted-by": "crossref", "first-page": "3010", "DOI": "10.1158/0008-5472.CAN-07-5796", "volume": "68", "author": "S Caserta", "year": "2008", "unstructured": "Caserta, S., Alessi, P., Guarnerio, J., Basso, V. & Mondino, A. Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses. Cancer Res. 68, 3010\u20133018 (2008).", "journal-title": "Cancer Res."}, {"key": "BFnrd4608_CR171", "doi-asserted-by": "crossref", "first-page": "1080", "DOI": "10.1073/pnas.1112648109", "volume": "109", "author": "JJ Moon", "year": "2012", "unstructured": "Moon, J. J. et al. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc. Natl Acad. Sci. USA 109, 1080\u20131085 (2012). A key paper demonstrating that targeting delivery to lymph nodes enhances vaccination. See also references 207 and 209.", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR172", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/S0169-409X(01)00154-5", "volume": "50", "author": "C Oussoren", "year": "2001", "unstructured": "Oussoren, C. & Storm, G. Liposomes to target the lymphatics by subcutaneous administration. Adv. Drug Deliv. Rev. 50, 143\u2013156 (2001).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR173", "first-page": "2505", "volume": "44", "author": "Y Takakura", "year": "1984", "unstructured": "Takakura, Y., Matsumoto, S., Hashida, M. & Sezaki, H. Enhanced lymphatic delivery of mitomycin C conjugated with dextran. Cancer Res. 44, 2505\u20132510 (1984).", "journal-title": "Cancer Res."}, {"key": "BFnrd4608_CR174", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.3109/02652049509087256", "volume": "12", "author": "CK Kim", "year": "1995", "unstructured": "Kim, C. K. & Han, J. H. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J. Microencapsul. 12, 437\u2013446 (1995).", "journal-title": "J. Microencapsul."}, {"key": "BFnrd4608_CR175", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1021/mp500531e", "volume": "12", "author": "LM Kaminskas", "year": "2015", "unstructured": "Kaminskas, L. M. et al. Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in rats. Mol. Pharm. 12, 432\u2013443 (2015).", "journal-title": "Mol. Pharm."}, {"key": "BFnrd4608_CR176", "doi-asserted-by": "crossref", "first-page": "876", "DOI": "10.1016/j.addr.2011.05.020", "volume": "63", "author": "SK Nune", "year": "2011", "unstructured": "Nune, S. K., Gunda, P., Majeti, B. K., Thallapally, P. K. & Forrest, M. L. Advances in lymphatic imaging and drug delivery. Adv. Drug Deliv. Rev. 63, 876\u2013885 (2011).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR177", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1124/jpet.103.052522", "volume": "306", "author": "DM Shackleford", "year": "2003", "unstructured": "Shackleford, D. M. et al. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J. Pharmacol. Exp. Ther. 306, 925\u2013933 (2003).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BFnrd4608_CR178", "doi-asserted-by": "crossref", "first-page": "700", "DOI": "10.1124/jpet.109.154542", "volume": "331", "author": "KL White", "year": "2009", "unstructured": "White, K. L. et al. Lymphatic transport of methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU. J. Pharmacol. Exp. Ther. 331, 700\u2013709 (2009).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BFnrd4608_CR179", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1111/j.2047-2927.2014.00216.x", "volume": "2", "author": "P Surampudi", "year": "2014", "unstructured": "Surampudi, P. et al. Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive. Andrology 2, 579\u2013587 (2014).", "journal-title": "Andrology"}, {"key": "BFnrd4608_CR180", "doi-asserted-by": "crossref", "first-page": "1599", "DOI": "10.1002/jps.1110", "volume": "90", "author": "SM Khoo", "year": "2001", "unstructured": "Khoo, S. M., Edwards, G. A., Porter, C. J. H. & Charman, W. N. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine. J. Pharm. Sci. 90, 1599\u20131607 (2001).", "journal-title": "J. Pharm. Sci."}, {"key": "BFnrd4608_CR181", "doi-asserted-by": "crossref", "first-page": "1486", "DOI": "10.1007/s11095-009-9860-z", "volume": "26", "author": "NL Trevaskis", "year": "2009", "unstructured": "Trevaskis, N. L. et al. Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism. Pharm. Res. 26, 1486\u20131495 (2009).", "journal-title": "Pharm. Res."}, {"key": "BFnrd4608_CR182", "doi-asserted-by": "crossref", "first-page": "729", "DOI": "10.1124/dmd.105.008102", "volume": "34", "author": "NL Trevaskis", "year": "2006", "unstructured": "Trevaskis, N. L., Porter, C. J. & Charman, W. N. An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat. Drug Metab. Dispos. 34, 729\u2013733 (2006).", "journal-title": "Drug Metab. Dispos."}, {"key": "BFnrd4608_CR183", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1016/j.jconrel.2012.12.018", "volume": "166", "author": "Z Zhang", "year": "2013", "unstructured": "Zhang, Z. et al. A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor. J. Control. Release 166, 30\u201337 (2013).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR184", "doi-asserted-by": "crossref", "first-page": "1200", "DOI": "10.1021/jm00362a021", "volume": "26", "author": "A Garzonaburbeh", "year": "1983", "unstructured": "Garzonaburbeh, A., Poupaert, J. H., Claesen, M., Dumont, P. & Atassi, G. 1,3-dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable anti-neoplastic agent. J. Med. Chem. 26, 1200\u20131203 (1983).", "journal-title": "J. Med. Chem."}, {"key": "BFnrd4608_CR185", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1016/j.jconrel.2013.03.006", "volume": "168", "author": "LM Kaminskas", "year": "2013", "unstructured": "Kaminskas, L. M. et al. PEGylation of interferon \u03b12 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases. J. Control. Release 168, 200\u2013208 (2013).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR186", "doi-asserted-by": "crossref", "first-page": "2513", "DOI": "10.1021/mp300132f", "volume": "9", "author": "S Li", "year": "2012", "unstructured": "Li, S., Goins, B., Hrycushko, B. A., Phillips, W. T. & Bao, A. Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes. Mol. Pharm. 9, 2513\u20132522 (2012).", "journal-title": "Mol. Pharm."}, {"key": "BFnrd4608_CR187", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.4155/tde.10.38", "volume": "1", "author": "S Cai", "year": "2010", "unstructured": "Cai, S., Xie, Y., Davies, N. M., Cohen, M. S. & Forrest, M. L. Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head and neck. Ther. Delivery 1, 237\u2013245 (2010).", "journal-title": "Ther. Delivery"}, {"key": "BFnrd4608_CR188", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/j.jconrel.2013.07.005", "volume": "171", "author": "L Qin", "year": "2013", "unstructured": "Qin, L. et al. Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumors. J. Control. Release 171, 133\u2013142 (2013).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR189", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1016/j.jconrel.2012.01.038", "volume": "159", "author": "M Rafi", "year": "2012", "unstructured": "Rafi, M. et al. Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis. J. Control. Release 159, 189\u2013196 (2012).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR190", "doi-asserted-by": "crossref", "first-page": "e61646", "DOI": "10.1371/journal.pone.0061646", "volume": "8", "author": "IC Kourtis", "year": "2013", "unstructured": "Kourtis, I. C. et al. Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS ONE 8, e61646 (2013).", "journal-title": "PLoS ONE"}, {"key": "BFnrd4608_CR191", "doi-asserted-by": "crossref", "first-page": "1810", "DOI": "10.1016/j.biomaterials.2012.11.038", "volume": "34", "author": "R Liu", "year": "2013", "unstructured": "Liu, R. et al. Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. Biomaterials 34, 1810\u20131819 (2013).", "journal-title": "Biomaterials"}, {"key": "BFnrd4608_CR192", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1016/j.jss.2008.02.048", "volume": "147", "author": "S Cai", "year": "2008", "unstructured": "Cai, S., Xie, Y., Bagby, T. R., Cohen, M. S. & Forrest, M. L. Intralymphatic chemotherapy using a hyaluronan\u2013cisplatin conjugate. J. Surg. Res. 147, 247\u2013252 (2008).", "journal-title": "J. Surg. Res."}, {"key": "BFnrd4608_CR193", "doi-asserted-by": "crossref", "first-page": "652", "DOI": "10.1111/j.1349-7006.1994.tb02409.x", "volume": "85", "author": "Y Akamo", "year": "1994", "unstructured": "Akamo, Y. et al. Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric carcinoma. Jpn J. Cancer Res. 85, 652\u2013658 (1994).", "journal-title": "Jpn J. Cancer Res."}, {"key": "BFnrd4608_CR194", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1016/j.jamcollsurg.2011.11.006", "volume": "214", "author": "OV Khullar", "year": "2012", "unstructured": "Khullar, O. V. et al. Nanoparticle migration and delivery of paclitaxel to regional lymph nodes in a large animal model. J. Am. Coll. Surg. 214, 328\u2013337 (2012).", "journal-title": "J. Am. Coll. Surg."}, {"key": "BFnrd4608_CR195", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1080/10611860400027725", "volume": "13", "author": "R Ling", "year": "2005", "unstructured": "Ling, R. et al. Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model. J. Drug Target. 13, 137\u2013142 (2005).", "journal-title": "J. Drug Target."}, {"key": "BFnrd4608_CR196", "doi-asserted-by": "crossref", "first-page": "1873", "DOI": "10.1016/j.ejca.2011.03.018", "volume": "47", "author": "F Yang", "year": "2011", "unstructured": "Yang, F. et al. Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment. Eur. J. Cancer 47, 1873\u20131882 (2011).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrd4608_CR197", "doi-asserted-by": "crossref", "first-page": "e73860", "DOI": "10.1371/journal.pone.0073860", "volume": "8", "author": "C Zhao", "year": "2013", "unstructured": "Zhao, C. et al. Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin. PLoS ONE 8, e73860 (2013).", "journal-title": "PLoS ONE"}, {"key": "BFnrd4608_CR198", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1016/j.jconrel.2011.08.009", "volume": "156", "author": "KY Dane", "year": "2011", "unstructured": "Dane, K. Y. et al. Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival. J. Control. Release 156, 154\u2013160 (2011).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR199", "doi-asserted-by": "crossref", "first-page": "2297", "DOI": "10.1021/mp100259a", "volume": "7", "author": "NL Trevaskis", "year": "2010", "unstructured": "Trevaskis, N. L., Charman, W. N. & Porter, C. J. Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation? Mol. Pharm. 7, 2297\u20132309 (2010).", "journal-title": "Mol. Pharm."}, {"key": "BFnrd4608_CR200", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/j.ajo.2012.01.034", "volume": "154", "author": "A Okanobo", "year": "2012", "unstructured": "Okanobo, A., Chauhan, S. K., Dastjerdi, M. H., Kodati, S. & Dana, R. Efficacy of topical blockade of interleukin-1 in experimental dry eye disease. Am. J. Ophthalmol. 154, 63\u201371 (2012).", "journal-title": "Am. J. Ophthalmol."}, {"key": "BFnrd4608_CR201", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1002/path.2935", "volume": "225", "author": "S Shinriki", "year": "2011", "unstructured": "Shinriki, S. et al. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma. J. Pathol. 225, 142\u2013150 (2011).", "journal-title": "J. Pathol."}, {"key": "BFnrd4608_CR202", "doi-asserted-by": "crossref", "first-page": "1610", "DOI": "10.1136/ard.2007.083394", "volume": "67", "author": "K Polzer", "year": "2008", "unstructured": "Polzer, K. et al. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Ann. Rheum. Dis. 67, 1610\u20131616 (2008).", "journal-title": "Ann. Rheum. Dis."}, {"key": "BFnrd4608_CR203", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1016/j.addr.2011.05.018", "volume": "63", "author": "I Pal", "year": "2011", "unstructured": "Pal, I. & Ramsey, J. D. The role of the lymphatic system in vaccine trafficking and immune response. Adv. Drug Deliv. Rev. 63, 909\u2013922 (2011).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR204", "doi-asserted-by": "crossref", "first-page": "1611", "DOI": "10.1084/jem.20132327", "volume": "211", "author": "MC Woodruff", "year": "2014", "unstructured": "Woodruff, M. C. et al. Trans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine. J. Exp. Med. 211, 1611\u20131621 (2014).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4608_CR205", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1097/ACI.0b013e3283310ff7", "volume": "9", "author": "G Senti", "year": "2009", "unstructured": "Senti, G., Johansen, P. & Kundig, T. M. Intralymphatic immunotherapy. Curr. Opin. Allergy Clin. Immunol. 9, 537\u2013543 (2009).", "journal-title": "Curr. Opin. Allergy Clin. Immunol."}, {"key": "BFnrd4608_CR206", "doi-asserted-by": "crossref", "first-page": "17908", "DOI": "10.1073/pnas.0803725105", "volume": "105", "author": "G Senti", "year": "2008", "unstructured": "Senti, G. et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc. Natl Acad. Sci. USA 105, 17908\u201317912 (2008). A clinical trial demonstrating the benefit of intralymphatic administration to induce allergen tolerance and reduce allergen-induced rhinoconjunctivitis.", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR207", "doi-asserted-by": "crossref", "first-page": "15745", "DOI": "10.1073/pnas.1105200108", "volume": "108", "author": "CM Jewell", "year": "2011", "unstructured": "Jewell, C. M., Bustamante L\u00f3pez, S. C. & Irvine, D. J. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc. Natl Acad. Sci. USA 108, 15745\u201315750 (2011).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR208", "doi-asserted-by": "crossref", "first-page": "3299", "DOI": "10.1073/pnas.051630798", "volume": "98", "author": "KJ Maloy", "year": "2001", "unstructured": "Maloy, K. J. et al. Intralymphatic immunization enhances DNA vaccination. Proc. Natl Acad. Sci. USA 98, 3299\u20133303 (2001).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR209", "doi-asserted-by": "crossref", "first-page": "19902", "DOI": "10.1073/pnas.1313152110", "volume": "110", "author": "A De Titta", "year": "2013", "unstructured": "De Titta, A. et al. Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc. Natl Acad. Sci. USA 110, 19902\u201319907 (2013).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR210", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1016/j.jconrel.2013.08.021", "volume": "172", "author": "Z Xu", "year": "2013", "unstructured": "Xu, Z. et al. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. J. Control. Release 172, 259\u2013265 (2013).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR211", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1038/nmat2960", "volume": "10", "author": "JJ Moon", "year": "2011", "unstructured": "Moon, J. J. et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat. Mater. 10, 243\u2013251 (2011).", "journal-title": "Nat. Mater."}, {"key": "BFnrd4608_CR212", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1038/nmat3222", "volume": "11", "author": "AL St John", "year": "2012", "unstructured": "St John, A. L., Chan, C. Y., Staats, H. F., Leong, K. W. & Abraham, S. N. Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat. Mater. 11, 250\u2013257 (2012).", "journal-title": "Nat. Mater."}, {"key": "BFnrd4608_CR213", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1158/2326-6066.CIR-14-0019-T", "volume": "2", "author": "L Jeanbart", "year": "2014", "unstructured": "Jeanbart, L. et al. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol. Res. 2, 436\u2013447 (2014).", "journal-title": "Cancer Immunol. Res."}, {"key": "BFnrd4608_CR214", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1016/j.biomaterials.2013.10.003", "volume": "35", "author": "SN Thomas", "year": "2014", "unstructured": "Thomas, S. N., Vokali, E., Lund, A. W., Hubbell, J. A. & Swartz, M. A. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials 35, 814\u2013824 (2014).", "journal-title": "Biomaterials"}, {"key": "BFnrd4608_CR215", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.4110/in.2012.12.5.165", "volume": "12", "author": "SH Kim", "year": "2012", "unstructured": "Kim, S. H., Lee, K. Y. & Jang, Y. S. Mucosal immune system and M cell-targeting strategies for oral mucosal vaccination. Immune Netw. 12, 165\u2013175 (2012).", "journal-title": "Immune Netw."}, {"key": "BFnrd4608_CR216", "doi-asserted-by": "crossref", "first-page": "1291", "DOI": "10.1038/nm.2866", "volume": "18", "author": "Q Zhu", "year": "2012", "unstructured": "Zhu, Q. et al. Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat. Med. 18, 1291\u20131296 (2012).", "journal-title": "Nat. Med."}, {"key": "BFnrd4608_CR217", "doi-asserted-by": "crossref", "first-page": "6959", "DOI": "10.1016/j.vaccine.2011.07.039", "volume": "29", "author": "M Ballester", "year": "2011", "unstructured": "Ballester, M. et al. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine 29, 6959\u20136966 (2011).", "journal-title": "Vaccine"}, {"key": "BFnrd4608_CR218", "doi-asserted-by": "crossref", "first-page": "E989", "DOI": "10.1073/pnas.1104264108", "volume": "108", "author": "C Nembrini", "year": "2011", "unstructured": "Nembrini, C. et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc. Natl Acad. Sci. USA 108, E989\u2013E997 (2011). This article demonstrates enhanced immunization and protection against influenza-ova infection via pulmonary administration of lymph node-targeted antigens in nanoparticles with CpG relative to administration of soluble antigens with CpG.", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR219", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1080/17402520600876804", "volume": "13", "author": "AMC Faria", "year": "2006", "unstructured": "Faria, A. M. C. & Weiner, H. L. Oral tolerance: therapeutic implications for autoimmune diseases. Clin. Dev. Immunol. 13, 143\u2013157 (2006).", "journal-title": "Clin. Dev. Immunol."}, {"key": "BFnrd4608_CR220", "doi-asserted-by": "crossref", "first-page": "665", "DOI": "10.1038/nri2153", "volume": "7", "author": "SD Miller", "year": "2007", "unstructured": "Miller, S. D., Turley, D. M. & Podojil, J. R. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol. 7, 665\u2013677 (2007).", "journal-title": "Nat. Rev. Immunol."}, {"key": "BFnrd4608_CR221", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1111/j.1600-065X.2011.01017.x", "volume": "241", "author": "HL Weiner", "year": "2011", "unstructured": "Weiner, H. L., da Cunha, A. P., Quintana, F. & Wu, H. Oral tolerance. Immunol. Rev. 241, 241\u2013259 (2011).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4608_CR222", "doi-asserted-by": "crossref", "first-page": "1359", "DOI": "10.1056/NEJMc1107841", "volume": "365", "author": "JD Scandling", "year": "2011", "unstructured": "Scandling, J. D., Busque, S., Shizuru, J. A., Engleman, E. G. & Strober, S. Induced immune tolerance for kidney transplantation. N. Engl. J. Med. 365, 1359\u20131360 (2011).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4608_CR223", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1111/j.0105-2896.2005.00280.x", "volume": "206", "author": "AMC Faria", "year": "2005", "unstructured": "Faria, A. M. C. & Weiner, H. L. Oral tolerance. Immunol. Rev. 206, 232\u2013259 (2005).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4608_CR224", "doi-asserted-by": "crossref", "first-page": "1344", "DOI": "10.1016/j.jaci.2008.02.037", "volume": "121", "author": "AW Burks", "year": "2008", "unstructured": "Burks, A. W., Laubach, S. & Jones, S. M. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J. Allergy Clin. Immunol. 121, 1344\u20131350 (2008).", "journal-title": "J. Allergy Clin. Immunol."}, {"key": "BFnrd4608_CR225", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1084/jem.20052016", "volume": "203", "author": "T Worbs", "year": "2006", "unstructured": "Worbs, T. et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203, 519\u2013527 (2006).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4608_CR226", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.0.CO;2-K", "volume": "32", "author": "TW Spahn", "year": "2002", "unstructured": "Spahn, T. W. et al. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur. J. Immunol. 32, 1109\u20131113 (2002).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4608_CR227", "doi-asserted-by": "crossref", "first-page": "1278", "DOI": "10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A", "volume": "31", "author": "TW Spahn", "year": "2001", "unstructured": "Spahn, T. W. et al. Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur. J. Immunol. 31, 1278\u20131287 (2001).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4608_CR228", "doi-asserted-by": "crossref", "first-page": "2234", "DOI": "10.1172/JCI19102", "volume": "115", "author": "TA Kraus", "year": "2005", "unstructured": "Kraus, T. A. et al. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J. Clin. Invest. 115, 2234\u20132243 (2005).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4608_CR229", "doi-asserted-by": "crossref", "first-page": "3310", "DOI": "10.1073/pnas.061412598", "volume": "98", "author": "K Fujihashi", "year": "2001", "unstructured": "Fujihashi, K. et al. Peyer's patches are required for oral tolerance to proteins. Proc. Natl Acad. Sci. USA 98, 3310\u20133315 (2001).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR230", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1053/j.gastro.2008.05.037", "volume": "135", "author": "H Suzuki", "year": "2008", "unstructured": "Suzuki, H. et al. Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology 135, 917\u2013925 (2008).", "journal-title": "Gastroenterology"}, {"key": "BFnrd4608_CR231", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1111/j.1348-0421.2002.tb02677.x", "volume": "46", "author": "K Masuda", "year": "2002", "unstructured": "Masuda, K., Horie, K., Suzuki, R., Yoshikawa, T. & Hirano, K. Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens. Microbiol. Immunol. 46, 55\u201358 (2002).", "journal-title": "Microbiol. Immunol."}, {"key": "BFnrd4608_CR232", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1136/ard.62.2.168", "volume": "62", "author": "W Kim", "year": "2003", "unstructured": "Kim, W. et al. Suppression of collagen-induced arthritis by single feeding of poilylactic-poilyglycolic acid entrapping immunodominant peptide of type II collagen: involvement of CD4+ IL-10+ T cells in Peyer's pathces. Ann. Rheum. Dis. 62, 168\u2013168 (2003).", "journal-title": "Ann. Rheum. Dis."}, {"key": "BFnrd4608_CR233", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.trim.2012.11.007", "volume": "28", "author": "K Goldmann", "year": "2013", "unstructured": "Goldmann, K., Hoffmann, J., Eckl, S., Spriewald, B. M. & Ensminger, S. M. Attenuation of transplant arteriosclerosis by oral feeding of major histocompatibility complex encoding chitosan-DNA nanoparticles. Transplant Immunol. 28, 9\u201313 (2013).", "journal-title": "Transplant Immunol."}, {"key": "BFnrd4608_CR234", "doi-asserted-by": "crossref", "first-page": "1196", "DOI": "10.1016/S0264-410X(99)00384-9", "volume": "18", "author": "S Pecquet", "year": "2000", "unstructured": "Pecquet, S. et al. Oral tolerance elicited in mice by \u03b2-lactoglobulin entrapped in biodegradable microspheres. Vaccine 18, 1196\u20131202 (2000).", "journal-title": "Vaccine"}, {"key": "BFnrd4608_CR235", "doi-asserted-by": "crossref", "first-page": "2582", "DOI": "10.1111/j.1600-6143.2011.03725.x", "volume": "11", "author": "AC Shirali", "year": "2011", "unstructured": "Shirali, A. C. et al. Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival. Am. J. Transplant. 11, 2582\u20132592 (2011).", "journal-title": "Am. J. Transplant."}, {"key": "BFnrd4608_CR236", "doi-asserted-by": "crossref", "first-page": "E156", "DOI": "10.1073/pnas.1408686111", "volume": "112", "author": "RA Maldonado", "year": "2015", "unstructured": "Maldonado, R. A. et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc. Natl Acad. Sci. USA 112, E156\u2013E165 (2015). Provides an innovative approach to enhance and prolong tolerance induction via the administration of 'tolerogenic' nanoparticles loaded with antigens and the tolerogenic immunomodulator rapamycin that are efficiently transport to lymphoid organs and captured by resident APCs.", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR237", "doi-asserted-by": "crossref", "first-page": "3556", "DOI": "10.4049/jimmunol.0802972", "volume": "182", "author": "C Capini", "year": "2009", "unstructured": "Capini, C. et al. Antigen-specific suppression of inflammatory arthritis using liposomes. J. Immunol. 182, 3556\u20133565 (2009).", "journal-title": "J. Immunol."}, {"key": "BFnrd4608_CR238", "doi-asserted-by": "crossref", "first-page": "1217", "DOI": "10.1038/nbt.2434", "volume": "30", "author": "DR Getts", "year": "2012", "unstructured": "Getts, D. R. et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat. Biotech. 30, 1217\u20131224 (2012).", "journal-title": "Nat. Biotech."}, {"key": "BFnrd4608_CR239", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1097/00126334-200312010-00005", "volume": "34", "author": "L Kinman", "year": "2003", "unstructured": "Kinman, L. et al. Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaques. J. Acquir. Immune Defic. Syndr. 34, 387\u2013397 (2003).", "journal-title": "J. Acquir. Immune Defic. Syndr."}, {"key": "BFnrd4608_CR240", "doi-asserted-by": "crossref", "first-page": "2625", "DOI": "10.1097/QAD.0000000000000421", "volume": "28", "author": "JP Freeling", "year": "2014", "unstructured": "Freeling, J. P., Koehn, J., Shu, C., Sun, J. & Ho, R. J. Y. Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood. AIDS 28, 2625\u20132627 (2014).", "journal-title": "AIDS"}, {"key": "BFnrd4608_CR241", "doi-asserted-by": "crossref", "first-page": "E2512", "DOI": "10.1073/pnas.1406554111", "volume": "111", "author": "JP Freeling", "year": "2014", "unstructured": "Freeling, J. P. & Ho, R. J. Y. Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence. Proc. Natl Acad. Sci. USA 111, E2512\u2013E2513 (2014).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR242", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1016/j.addr.2009.11.017", "volume": "62", "author": "J das Neves", "year": "2010", "unstructured": "das Neves, J., Amiji, M. M., Bahia, M. F. & Sarmento, B. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS. Adv. Drug Deliv. Rev. 62, 458\u2013477 (2010).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR243", "doi-asserted-by": "crossref", "first-page": "4186", "DOI": "10.2174/0929867321666140826114135", "volume": "21", "author": "BJ Edagwa", "year": "2014", "unstructured": "Edagwa, B. J., Zhou, T., McMillan, J. M., Liu, X. M. & Gendelman, H. E. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies. Curr. Med. Chem. 21, 4186\u20134198 (2014).", "journal-title": "Curr. Med. Chem."}, {"key": "BFnrd4608_CR244", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1016/j.jconrel.2009.05.007", "volume": "138", "author": "A Sosnik", "year": "2009", "unstructured": "Sosnik, A., Chiappetta, D. A. & Carcaboso, \u00c1. M. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead. J. Control. Release 138, 2\u201315 (2009).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR245", "doi-asserted-by": "crossref", "first-page": "2237", "DOI": "10.1016/j.bmcl.2007.01.062", "volume": "17", "author": "M Lalanne", "year": "2007", "unstructured": "Lalanne, M. et al. Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV. Bioorg. Med. Chem. Lett. 17, 2237\u20132240 (2007).", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "BFnrd4608_CR246", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1016/j.ijpharm.2011.05.005", "volume": "414", "author": "R Skanji", "year": "2011", "unstructured": "Skanji, R. et al. A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary. Int. J. Pharm. 414, 285\u2013297 (2011).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR247", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.biomaterials.2014.11.012", "volume": "41", "author": "P Puligujja", "year": "2015", "unstructured": "Puligujja, P. et al. Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials 41, 141\u2013150 (2015).", "journal-title": "Biomaterials"}, {"key": "BFnrd4608_CR248", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1007/BF01483589", "volume": "54", "author": "HJ Horst", "year": "1976", "unstructured": "Horst, H. J. et al. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin. Wochenschr. 54, 875\u2013879 (1976). One of the very few studies to have quantified drug uptake into the lymph in humans.", "journal-title": "Klin. Wochenschr."}, {"key": "BFnrd4608_CR249", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/S0169-409X(01)00148-X", "volume": "50", "author": "GA Edwards", "year": "2001", "unstructured": "Edwards, G. A., Porter, C. J., Caliph, S. M., Khoo, S. M. & Charman, W. N. Animal models for the study of intestinal lymphatic drug transport. Adv. Drug Deliv. Rev. 50, 45\u201360 (2001).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR250", "doi-asserted-by": "crossref", "first-page": "e28", "DOI": "10.1056/NEJMicm074093", "volume": "359", "author": "M Seeger", "year": "2008", "unstructured": "Seeger, M. & Bewig, B. Ultrasound imaging of the thoracic duct. N. Engl. J. Med. 359, e28 (2008).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4608_CR251", "first-page": "380", "volume": "19", "author": "G Nadolski", "year": "2013", "unstructured": "Nadolski, G. & Itkin, M. Thoracic duct embolization for the management of chylothoraces. Curr. Opin. Pulm. Med. 19, 380\u2013386 (2013).", "journal-title": "Curr. Opin. Pulm. Med."}, {"key": "BFnrd4608_CR252", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/j.coche.2014.11.003", "volume": "7", "author": "SN Thomas", "year": "2015", "unstructured": "Thomas, S. N. & Schudel, A. Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery. Curr. Opin. Chem. Engineer. 7, 65\u201374 (2015).", "journal-title": "Curr. Opin. Chem. Engineer."}, {"key": "BFnrd4608_CR253", "doi-asserted-by": "crossref", "first-page": "920", "DOI": "10.1161/CIRCRESAHA.109.207274", "volume": "106", "author": "DO Miteva", "year": "2010", "unstructured": "Miteva, D. O. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ. Res. 106, 920\u2013931 (2010).", "journal-title": "Circ. Res."}, {"key": "BFnrd4608_CR254", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1083/jcb.144.4.789", "volume": "144", "author": "S Banerji", "year": "1999", "unstructured": "Banerji, S. et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789\u2013801 (1999).", "journal-title": "J. Cell Biol."}, {"key": "BFnrd4608_CR255", "doi-asserted-by": "crossref", "first-page": "1224", "DOI": "10.1002/bit.22337", "volume": "103", "author": "JB Dixon", "year": "2009", "unstructured": "Dixon, J. B., Raghunathan, S. & Swartz, M. A. A tissue-engineered model of the intestinal lacteal for evaluating lipid transport by lymphatics. Biotechnol. Bioengineer. 103, 1224\u20131235 (2009).", "journal-title": "Biotechnol. Bioengineer."}, {"key": "BFnrd4608_CR256", "doi-asserted-by": "crossref", "first-page": "L187", "DOI": "10.1152/ajplung.00152.2002", "volume": "284", "author": "TA John", "year": "2003", "unstructured": "John, T. A., Vogel, S. M., Tiruppathi, C., Malik, A. B. & Minshall, R. D. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L187\u2013L196 (2003).", "journal-title": "Am. J. Physiol. Lung Cell. Mol. Physiol."}, {"key": "BFnrd4608_CR257", "doi-asserted-by": "crossref", "first-page": "48619", "DOI": "10.1074/jbc.C100613200", "volume": "276", "author": "W Schubert", "year": "2001", "unstructured": "Schubert, W. et al. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J. Biol. Chem. 276, 48619\u201348622 (2001).", "journal-title": "J. Biol. Chem."}, {"key": "BFnrd4608_CR258", "doi-asserted-by": "crossref", "first-page": "518", "DOI": "10.1089/rej.2013.1530", "volume": "16", "author": "AR Mendelsohn", "year": "2013", "unstructured": "Mendelsohn, A. R. & Larrick, J. W. Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases. Rejuven. Res. 16, 518\u2013523 (2013).", "journal-title": "Rejuven. Res."}, {"key": "BFnrd4608_CR259", "doi-asserted-by": "crossref", "first-page": "2582", "DOI": "10.1038/srep02582", "volume": "3", "author": "VR Thrane", "year": "2013", "unstructured": "Thrane, V. R. et al. Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain. Sci. Rep. 3, 2582 (2013).", "journal-title": "Sci. Rep."}, {"issue": "Suppl. 1", "key": "BFnrd4608_CR260", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/S0169-409X(01)00184-3", "volume": "50", "author": "AT Florence", "year": "2001", "unstructured": "Florence, A. T. & Hussain, N. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv. Drug Deliv. Rev. 50 (Suppl. 1), 69\u201389 (2001).", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "BFnrd4608_CR261", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.jconrel.2006.08.013", "volume": "116", "author": "A des Rieux", "year": "2006", "unstructured": "des Rieux, A., Fievez, V., Garinot, M., Schneider, Y. J. & Preat, V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J. Control. Release 116, 1\u201327 (2006).", "journal-title": "J. Control. Release"}, {"key": "BFnrd4608_CR262", "doi-asserted-by": "crossref", "first-page": "S5", "DOI": "10.1016/j.nano.2012.07.005", "volume": "8", "author": "AC Hunter", "year": "2012", "unstructured": "Hunter, A. C., Elsom, J., Wibroe, P. P. & Moghimi, S. M. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomedicine 8, S5\u2013S20 (2012).", "journal-title": "Nanomedicine"}, {"key": "BFnrd4608_CR263", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1016/j.ejpb.2013.12.015", "volume": "87", "author": "PR Ravi", "year": "2014", "unstructured": "Ravi, P. R., Aditya, N., Kathuria, H., Malekar, S. & Vats, R. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur. J. Pharm. Biopharm. 87, 114\u2013124 (2014).", "journal-title": "Eur. J. Pharm. Biopharm."}, {"key": "BFnrd4608_CR264", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1016/j.ejps.2011.04.011", "volume": "43", "author": "M Sun", "year": "2011", "unstructured": "Sun, M. et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: Linear correlation with oral bioavailabilities in rats. Eur. J. Pharm. Sci. 43, 132\u2013140 (2011).", "journal-title": "Eur. J. Pharm. Sci."}, {"key": "BFnrd4608_CR265", "doi-asserted-by": "crossref", "first-page": "374", "DOI": "10.1016/j.ijpharm.2013.05.021", "volume": "452", "author": "Z Zhang", "year": "2013", "unstructured": "Zhang, Z. et al. Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats. Int. J. Pharm. 452, 374\u2013381 (2013).", "journal-title": "Int. J. Pharm."}, {"key": "BFnrd4608_CR266", "doi-asserted-by": "crossref", "first-page": "2565", "DOI": "10.1016/j.biomaterials.2012.12.043", "volume": "34", "author": "C Fu", "year": "2013", "unstructured": "Fu, C. et al. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials 34, 2565\u20132575 (2013).", "journal-title": "Biomaterials"}, {"key": "BFnrd4608_CR267", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/j.ejps.2004.12.006", "volume": "24", "author": "A Dahan", "year": "2005", "unstructured": "Dahan, A. & Hoffman, A. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur. J. Pharm. Sci. 24, 381\u2013388 (2005).", "journal-title": "Eur. J. Pharm. Sci."}, {"key": "BFnrd4608_CR268", "first-page": "147", "volume": "76", "author": "A Bernard", "year": "1980", "unstructured": "Bernard, A., Carlier, H. & Caselli, C. Biochemical and ultrastructural study of actidione-cycloheximide effect on fat intestinal absorption in the rat (author's transl). J. Physiol. (Paris). 76, 147\u2013157 (1980) (in French).", "journal-title": "J. Physiol. (Paris)."}, {"key": "BFnrd4608_CR269", "doi-asserted-by": "crossref", "first-page": "4499", "DOI": "10.1038/onc.2011.602", "volume": "31", "author": "A Alitalo", "year": "2012", "unstructured": "Alitalo, A. & Detmar, M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31, 4499\u20134508 (2012).", "journal-title": "Oncogene"}, {"key": "BFnrd4608_CR270", "doi-asserted-by": "crossref", "first-page": "1328", "DOI": "10.2353/ajpath.2009.080963", "volume": "175", "author": "YL Hwee", "year": "2009", "unstructured": "Hwee, Y. L. et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am. J. Pathol. 175, 1328\u20131337 (2009).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrd4608_CR271", "doi-asserted-by": "crossref", "first-page": "18784", "DOI": "10.1073/pnas.1116152108", "volume": "108", "author": "S Liao", "year": "2011", "unstructured": "Liao, S. et al. Impaired lymphatic contraction associated with immunosuppression. Proc. Natl Acad. Sci. USA 108, 18784\u201318789 (2011).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR272", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/j.ejps.2012.04.016", "volume": "47", "author": "TR Bagby", "year": "2012", "unstructured": "Bagby, T. R. et al. Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character. Eur. J. Pharm. Sci. 47, 287\u2013294 (2012).", "journal-title": "Eur. J. Pharm. Sci."}, {"key": "BFnrd4608_CR273", "doi-asserted-by": "crossref", "first-page": "2892", "DOI": "10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I", "volume": "31", "author": "M Karlsson", "year": "2001", "unstructured": "Karlsson, M. et al. \u201cTolerosomes\u201d are produced by intestinal epithelial cells. Eur. J. Immunol. 31, 2892\u20132900 (2001).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4608_CR274", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1038/mi.2010.5", "volume": "3", "author": "S Menard", "year": "2010", "unstructured": "Menard, S., Cerf-Bensussan, N. & Heyman, M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol. 3, 247\u2013259 (2010).", "journal-title": "Mucosal Immunol."}, {"key": "BFnrd4608_CR275", "doi-asserted-by": "crossref", "first-page": "e8442", "DOI": "10.1371/journal.pone.0008442", "volume": "4", "author": "YH Wang", "year": "2009", "unstructured": "Wang, Y. H. et al. Chylomicrons promote intestinal absorption and systemic dissemination of dietary antigen (ovalbumin) in mice. PLoS ONE 4, e8442 (2009).", "journal-title": "PLoS ONE"}, {"key": "BFnrd4608_CR276", "doi-asserted-by": "crossref", "first-page": "6110", "DOI": "10.1073/pnas.0400969101", "volume": "101", "author": "MH Jang", "year": "2004", "unstructured": "Jang, M. H. et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl Acad. Sci. USA 101, 6110\u20136115 (2004).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4608_CR277", "author": "MR Neutra", "first-page": "111", "year": "2005", "unstructured": "Neutra, M. R. & Kraehenbuhl, J. P. in Mucosal Immunology 3rd edn (eds Mestecky, J. et al.) 111\u2013130 (Elsevier, 2005).", "volume-title": "Mucosal Immunology", "DOI": "10.1016/B978-012491543-5/50011-5", "doi-asserted-by": "crossref"}, {"key": "BFnrd4608_CR278", "doi-asserted-by": "crossref", "first-page": "2395", "DOI": "10.1002/jps.23597", "volume": "102", "author": "SM Caliph", "year": "2013", "unstructured": "Caliph, S. M. et al. The impact of lymphatic transport on the systemic disposition of lipophilic drugs. J. Pharm. Sci. 102, 2395\u20132408 (2013).", "journal-title": "J. Pharm. Sci."}, {"key": "BFnrd4608_CR279", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1016/j.immuni.2007.06.007", "volume": "27", "author": "YR Carrasco", "year": "2007", "unstructured": "Carrasco, Y. R. & Batista, F. D. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 27, 160\u2013171 (2007).", "journal-title": "Immunity"}, {"key": "BFnrd4608_CR280", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1038/nature06287", "volume": "450", "author": "T Junt", "year": "2007", "unstructured": "Junt, T. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450, 110\u2013114 (2007).", "journal-title": "Nature"}], "container-title": ["Nature Reviews Drug Discovery"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/nrd4608.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrd4608", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrd4608.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T21:43:07Z", "timestamp": 1569879787000}, "score": 18.23833, "issued": {"date-parts": [[2015, 10, 16]]}, "references-count": 280, "journal-issue": {"published-print": {"date-parts": [[2015, 11]]}, "issue": "11"}, "alternative-id": ["BFnrd4608"], "URL": "http://dx.doi.org/10.1038/nrd4608", "relation": {"cites": []}, "ISSN": ["1474-1776", "1474-1784"], "issn-type": [{"value": "1474-1776", "type": "print"}, {"value": "1474-1784", "type": "electronic"}], "assertion": [{"value": "16 October 2015", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "C.J.H.P. and N.L.T. are named inventors on a patent application in the area of lymph-targeted prodrugs.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T21:33:03Z", "timestamp": 1575408783282}, "reference-count": 0, "publisher": "Alphamed Press", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Oncologist"], "published-print": {"date-parts": [[2014, 1, 1]]}, "DOI": "10.1634/theoncologist.2013-0077", "type": "journal-article", "created": {"date-parts": [[2013, 12, 6]], "date-time": "2013-12-06T02:35:00Z", "timestamp": 1386297300000}, "page": "94-99", "source": "Crossref", "is-referenced-by-count": 25, "title": ["U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia"], "prefix": "10.1634", "volume": "19", "author": [{"given": "F.", "family": "Alvandi", "sequence": "first", "affiliation": []}, {"given": "V. E.", "family": "Kwitkowski", "sequence": "additional", "affiliation": []}, {"given": "C.-W.", "family": "Ko", "sequence": "additional", "affiliation": []}, {"given": "M. D.", "family": "Rothmann", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Ricci", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Saber", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Ghosh", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Brown", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Pfeiler", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Chikhale", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Grillo", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Bullock", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Kane", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "A. T.", "family": "Farrell", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Pazdur", "sequence": "additional", "affiliation": []}], "member": "638", "published-online": {"date-parts": [[2013, 12, 5]]}, "container-title": ["The Oncologist"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1634/theoncologist.2013-0077", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 22]], "date-time": "2016-12-22T23:58:59Z", "timestamp": 1482451139000}, "score": 17.672703, "issued": {"date-parts": [[2013, 12, 5]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 1, 17]]}, "published-print": {"date-parts": [[2014, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1634/theoncologist.2013-0077", "ISSN": ["1083-7159", "1549-490X"], "issn-type": [{"value": "1083-7159", "type": "print"}, {"value": "1549-490X", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:38:51Z", "timestamp": 1574887131688}, "reference-count": 92, "publisher": "Future Medicine Ltd", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nanomedicine"], "published-print": {"date-parts": [[2019, 6]]}, "DOI": "10.2217/nnm-2018-0478", "type": "journal-article", "created": {"date-parts": [[2019, 6, 5]], "date-time": "2019-06-05T15:16:47Z", "timestamp": 1559747807000}, "page": "1605-1621", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Drug formulation and nanomedicine approaches to targeting lymphatic cancer metastases"], "prefix": "10.2217", "volume": "14", "author": [{"given": "Lili", "family": "Wang", "sequence": "first", "affiliation": [{"name": "School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia"}]}, {"given": "Christopher", "family": "Subasic", "sequence": "additional", "affiliation": [{"name": "School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia"}]}, {"given": "Rodney F", "family": "Minchin", "sequence": "additional", "affiliation": [{"name": "School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia"}]}, {"given": "Lisa M", "family": "Kaminskas", "sequence": "additional", "affiliation": [{"name": "School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia"}]}], "member": "1057", "reference": [{"issue": "6", "key": "B1", "first-page": "931", "volume": "132", "author": "Disibio G", "year": "2008", "journal-title": "Arch. Pathol. Lab. Med."}, {"key": "B2", "DOI": "10.1111/j.1749-6632.2002.tb04876.x", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1038/nrc863", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1038/nm1469", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1080/17425247.2018.1446937", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1002/jso.21535", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1016/S1470-2045(01)00519-8", "doi-asserted-by": "publisher"}, {"key": "B8", "DOI": "10.1007/978-3-642-57151-0_6", "doi-asserted-by": "publisher"}, {"key": "B9", "DOI": "10.3233/BD-2010-0299", "doi-asserted-by": "publisher"}, {"key": "B10", "DOI": "10.1016/j.ejso.2003.09.008", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1001/archsurg.137.5.606", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1038/84643", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1002/jso.21744", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "B14", "first-page": "1187", "volume": "165", "author": "Sipos B", "year": "2004", "journal-title": "Am. J. Physiol."}, {"issue": "5", "key": "B15", "first-page": "1315", "volume": "62", "author": "Beasley NJ", "year": "2002", "journal-title": "Cancer Res."}, {"key": "B16", "DOI": "10.1002/cncr.20454", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.18632/oncotarget.13752", "doi-asserted-by": "publisher"}, {"key": "B18", "DOI": "10.1186/s12885-015-1501-9", "doi-asserted-by": "publisher"}, {"key": "B19", "DOI": "10.3322/CA.2007.0003", "doi-asserted-by": "publisher"}, {"key": "B20", "DOI": "10.1016/j.jconrel.2013.08.004", "doi-asserted-by": "publisher"}, {"key": "B21", "DOI": "10.1016/j.ijpharm.2009.06.026", "doi-asserted-by": "publisher"}, {"key": "B22", "DOI": "10.1038/nrd4608", "doi-asserted-by": "publisher"}, {"key": "B23", "DOI": "10.1016/j.biomaterials.2012.11.038", "doi-asserted-by": "publisher"}, {"key": "B24", "DOI": "10.1016/j.jconrel.2013.07.005", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "B25", "first-page": "367", "volume": "73", "author": "Jitendra Sharma PK", "year": "2011", "journal-title": "Indian J. Pharm. Sci."}, {"key": "B26", "DOI": "10.1002/jps.20515", "doi-asserted-by": "publisher"}, {"key": "B27", "DOI": "10.1248/bpb1978.11.700", "doi-asserted-by": "publisher"}, {"key": "B28", "DOI": "10.1016/j.jconrel.2013.03.006", "doi-asserted-by": "publisher"}, {"key": "B29", "DOI": "10.1007/s11095-006-9064-8", "doi-asserted-by": "publisher"}, {"key": "B30", "DOI": "10.1073/pnas.0803728105", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.3109/1061186X.2014.897708", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1016/j.jamcollsurg.2011.11.006", "doi-asserted-by": "publisher"}, {"key": "B33", "DOI": "10.1007/s00280-006-0256-z", "doi-asserted-by": "publisher"}, {"key": "B34", "DOI": "10.1088/0957-4484/22/41/415103", "doi-asserted-by": "publisher"}, {"key": "B35", "DOI": "10.1016/j.nano.2011.05.013", "doi-asserted-by": "publisher"}, {"key": "B36", "DOI": "10.1016/j.jconrel.2011.07.034", "doi-asserted-by": "publisher"}, {"key": "B37", "DOI": "10.3109/02652049509087256", "doi-asserted-by": "publisher"}, {"issue": "15", "key": "B38", "first-page": "3320", "volume": "58", "author": "Lopes De Menezes DE", "year": "1998", "journal-title": "Cancer Res."}, {"key": "B39", "DOI": "10.1021/mp500531e", "doi-asserted-by": "publisher"}, {"key": "B40", "DOI": "10.1016/j.nano.2017.08.003", "doi-asserted-by": "publisher"}, {"key": "B41", "DOI": "10.1021/nn5070259", "doi-asserted-by": "publisher"}, {"key": "B42", "DOI": "10.1016/j.nano.2008.08.003", "doi-asserted-by": "publisher"}, {"key": "B43", "DOI": "10.1016/j.ejps.2006.01.001", "doi-asserted-by": "publisher"}, {"key": "B44", "DOI": "10.2147/IJN.S120685", "doi-asserted-by": "publisher"}, {"key": "B45", "DOI": "10.1039/b908012k", "doi-asserted-by": "publisher"}, {"key": "B46", "DOI": "10.1593/neo.08302", "doi-asserted-by": "publisher"}, {"key": "B47", "DOI": "10.1016/j.jconrel.2013.12.031", "doi-asserted-by": "publisher"}, {"key": "B48", "DOI": "10.1021/acs.molpharmaceut.6b00195", "doi-asserted-by": "publisher"}, {"key": "B49", "DOI": "10.1002/anie.201604207", "doi-asserted-by": "publisher"}, {"key": "B50", "DOI": "10.1016/j.jconrel.2018.07.022", "doi-asserted-by": "publisher"}, {"key": "B51", "DOI": "10.1038/clpt.2012.73", "doi-asserted-by": "publisher"}, {"key": "B52", "DOI": "10.1016/j.carbpol.2015.10.080", "doi-asserted-by": "publisher"}, {"key": "B53", "DOI": "10.1016/j.jconrel.2006.01.006", "doi-asserted-by": "publisher"}, {"key": "B54", "DOI": "10.1016/j.jconrel.2015.11.013", "doi-asserted-by": "publisher"}, {"key": "B55", "DOI": "10.1016/S0169-409X(01)00154-5", "doi-asserted-by": "publisher"}, {"key": "B56", "author": "Ali Khan A", "volume": "8", "first-page": "2733", "year": "2013", "journal-title": "Int. J. Nanomed."}, {"key": "B57", "DOI": "10.1016/S0005-2736(97)00122-3", "doi-asserted-by": "publisher"}, {"key": "B58", "DOI": "10.1002/jps.21970", "doi-asserted-by": "publisher"}, {"key": "B59", "DOI": "10.1016/j.jconrel.2009.08.005", "doi-asserted-by": "publisher"}, {"key": "B60", "DOI": "10.1016/j.addr.2011.05.016", "doi-asserted-by": "publisher"}, {"key": "B61", "DOI": "10.2217/nnm.11.67", "doi-asserted-by": "publisher"}, {"key": "B62", "DOI": "10.1021/mp7001208", "doi-asserted-by": "publisher"}, {"key": "B63", "DOI": "10.1007/s12272-018-1060-0", "doi-asserted-by": "publisher"}, {"key": "B64", "DOI": "10.1016/j.ejpb.2007.09.018", "doi-asserted-by": "publisher"}, {"key": "B65", "DOI": "10.1016/S0169-409X(02)00118-7", "doi-asserted-by": "publisher"}, {"key": "B66", "DOI": "10.1539/joh.17-0089-RA", "doi-asserted-by": "publisher"}, {"key": "B67", "DOI": "10.1155/2014/180549", "doi-asserted-by": "publisher"}, {"key": "B68", "DOI": "10.1002/(SICI)1099-081X(199804)19:3<193::AID-BDD88>3.0.CO;2-V", "doi-asserted-by": "publisher"}, {"key": "B69", "DOI": "10.2147/IJN.S165210", "doi-asserted-by": "publisher"}, {"key": "B70", "DOI": "10.1007/s00432-014-1767-3", "doi-asserted-by": "publisher"}, {"key": "B71", "DOI": "10.1158/0008-5472.CAN-07-6752", "doi-asserted-by": "publisher"}, {"key": "B72", "DOI": "10.1038/nm720", "doi-asserted-by": "publisher"}, {"key": "B73", "DOI": "10.1021/bc100403e", "doi-asserted-by": "publisher"}, {"key": "B74", "DOI": "10.1021/mp3002107", "doi-asserted-by": "publisher"}, {"key": "B75", "DOI": "10.1016/j.ejpb.2019.01.017", "doi-asserted-by": "publisher"}, {"key": "B76", "DOI": "10.1084/jem.194.8.1033", "doi-asserted-by": "publisher"}, {"key": "B77", "DOI": "10.1182/blood-2007-10-118984", "doi-asserted-by": "publisher"}, {"key": "B78", "DOI": "10.1080/10611860802475688", "doi-asserted-by": "publisher"}, {"key": "B79", "DOI": "10.1016/j.surg.2005.06.038", "doi-asserted-by": "publisher"}, {"key": "B80", "DOI": "10.1016/j.addr.2007.11.001", "doi-asserted-by": "publisher"}, {"key": "B81", "DOI": "10.7150/thno.25608", "doi-asserted-by": "publisher"}, {"key": "B82", "DOI": "10.1021/acs.molpharmaceut.5b00749", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "B83", "first-page": "25", "volume": "4", "author": "Bocci V", "year": "1990", "journal-title": "J. Biol. Regul. Homeost. Agents"}, {"issue": "4", "key": "B84", "first-page": "390", "volume": "7", "author": "Bocci V", "year": "1988", "journal-title": "J. Biol. Response Mod."}, {"key": "B85", "DOI": "10.1038/nature12978", "doi-asserted-by": "publisher"}, {"key": "B86", "DOI": "10.1016/j.vaccine.2011.11.056", "doi-asserted-by": "publisher"}, {"key": "B87", "DOI": "10.1517/14728210902907847", "doi-asserted-by": "publisher"}, {"key": "B88", "DOI": "10.1021/acs.biomac.7b00794", "doi-asserted-by": "publisher"}, {"key": "B89", "DOI": "10.1016/j.colsurfb.2006.02.006", "doi-asserted-by": "publisher"}, {"key": "B90", "DOI": "10.1002/jgm.634", "doi-asserted-by": "publisher"}, {"key": "B91", "DOI": "10.1073/pnas.1304987110", "doi-asserted-by": "publisher"}, {"key": "B92", "DOI": "10.1021/mp2005966", "doi-asserted-by": "publisher"}], "container-title": ["Nanomedicine"], "language": "en", "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2018-0478", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:26:51Z", "timestamp": 1574245611000}, "score": 16.14017, "issued": {"date-parts": [[2019, 6]]}, "references-count": 92, "journal-issue": {"published-print": {"date-parts": [[2019, 6]]}, "issue": "12"}, "alternative-id": ["10.2217/nnm-2018-0478"], "URL": "http://dx.doi.org/10.2217/nnm-2018-0478", "relation": {"cites": []}, "ISSN": ["1743-5889", "1748-6963"], "issn-type": [{"value": "1743-5889", "type": "print"}, {"value": "1748-6963", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T07:25:39Z", "timestamp": 1575271539452}, "publisher-location": "New York, NY", "reference-count": 37, "publisher": "Springer New York", "isbn-type": [{"value": "9781493977550", "type": "print"}, {"value": "9781493977567", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-1-4939-7756-7_14", "type": "book-chapter", "created": {"date-parts": [[2018, 3, 28]], "date-time": "2018-03-28T13:08:10Z", "timestamp": 1522242490000}, "page": "271-284", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Prediction and Optimization of Pharmacokinetic and Toxicity Properties of the Ligand"], "prefix": "10.1007", "author": [{"given": "Douglas E. V.", "family": "Pires", "sequence": "first", "affiliation": []}, {"given": "Lisa M.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "David B.", "family": "Ascher", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 3, 29]]}, "reference": [{"issue": "4", "key": "14_CR1", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.2174/138920010791514306", "volume": "11", "author": "MT Khan", "year": "2010", "unstructured": "Khan MT (2010) Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr Drug Metab 11(4):285\u2013295", "journal-title": "Curr Drug Metab"}, {"issue": "23\u201324", "key": "14_CR2", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1016/j.drudis.2007.08.004", "volume": "12", "author": "MA Lill", "year": "2007", "unstructured": "Lill MA (2007) Multi-dimensional QSAR in drug discovery. Drug Discov Today 12(23\u201324):1013\u20131017", "journal-title": "Drug Discov Today"}, {"issue": "5", "key": "14_CR3", "doi-asserted-by": "crossref", "first-page": "1847", "DOI": "10.1021/ci7000633", "volume": "47", "author": "O Obrezanova", "year": "2007", "unstructured": "Obrezanova O, Csanyi G, Gola JM, Segall MD (2007) Gaussian processes: a method for automatic QSAR modeling of ADME properties. J Chem Inf Model 47(5):1847\u20131857", "journal-title": "J Chem Inf Model"}, {"issue": "Web Server issu", "key": "14_CR4", "doi-asserted-by": "crossref", "first-page": "W53", "DOI": "10.1093/nar/gku401", "volume": "42", "author": "MN Drwal", "year": "2014", "unstructured": "Drwal MN, Banerjee P, Dunkel M, Wettig MR, Preissner R (2014) ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res 42(Web Server issue):W53\u2013W58", "journal-title": "Nucleic Acids Res"}, {"issue": "4", "key": "14_CR5", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1002/qsar.200510135", "volume": "25", "author": "H Fr\u00f6hlich", "year": "2006", "unstructured": "Fr\u00f6hlich H, Wegner JK, Sieker F, Zell A (2006) Kernel functions for attributed molecular graphs\u2013a new similarity-based approach to ADME prediction in classification and regression. QSAR Comb Sci 25(4):317\u2013326", "journal-title": "QSAR Comb Sci"}, {"issue": "1\u20132", "key": "14_CR6", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1016/j.drudis.2011.10.023", "volume": "17", "author": "G Moroy", "year": "2012", "unstructured": "Moroy G, Martiny VY, Vayer P, Villoutreix BO, Miteva MA (2012) Toward in silico structure-based ADMET prediction in drug discovery. Drug Discov Today 17(1\u20132):44\u201355", "journal-title": "Drug Discov Today"}, {"issue": "W1", "key": "14_CR7", "doi-asserted-by": "crossref", "first-page": "W557", "DOI": "10.1093/nar/gkw390", "volume": "44", "author": "DE Pires", "year": "2016", "unstructured": "Pires DE, Ascher DB (2016) CSM-lig: a web server for assessing and comparing protein-small molecule affinities. Nucleic Acids Res 44(W1):W557\u2013W561", "journal-title": "Nucleic Acids Res"}, {"issue": "11", "key": "14_CR8", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.2174/15680266113139990037", "volume": "13", "author": "OF Guner", "year": "2013", "unstructured": "Guner OF, Bowen JP (2013) Pharmacophore modeling for ADME. Curr Top Med Chem 13(11):1327\u20131342", "journal-title": "Curr Top Med Chem"}, {"issue": "9", "key": "14_CR9", "doi-asserted-by": "crossref", "first-page": "4066", "DOI": "10.1021/acs.jmedchem.5b00104", "volume": "58", "author": "DE Pires", "year": "2015", "unstructured": "Pires DE, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072", "journal-title": "J Med Chem"}, {"key": "14_CR10", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1186/1758-2946-3-33", "volume": "3", "author": "NM O'Boyle", "year": "2011", "unstructured": "O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3:33", "journal-title": "J Cheminform"}, {"issue": "11", "key": "14_CR11", "doi-asserted-by": "crossref", "first-page": "6147", "DOI": "10.1039/C5SC02155C", "volume": "6", "author": "AG Sigurdardottir", "year": "2015", "unstructured": "Sigurdardottir AG, Winter A, Sobkowicz A, Fragai M, Chirgadze D, Ascher DB, Blundell TL, Gherardi E (2015) Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding. Chem Sci 6(11):6147\u20136157", "journal-title": "Chem Sci"}, {"issue": "12", "key": "14_CR12", "doi-asserted-by": "crossref", "first-page": "4209", "DOI": "10.1096/fj.08-112227", "volume": "22", "author": "AL Albiston", "year": "2008", "unstructured": "Albiston AL, Morton CJ, Ng HL, Pham V, Yeatman HR, Ye S, Fernando RN, De Bundel D, Ascher DB, Mendelsohn FA, Parker MW, Chai SY (2008) Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase. FASEB J 22(12):4209\u20134217", "journal-title": "FASEB J"}, {"key": "14_CR13", "doi-asserted-by": "crossref", "first-page": "4765", "DOI": "10.1038/srep04765", "volume": "4", "author": "DB Ascher", "year": "2014", "unstructured": "Ascher DB, Wielens J, Nero TL, Doughty L, Morton CJ, Parker MW (2014) Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA. Sci Rep 4:4765", "journal-title": "Sci Rep"}, {"issue": "Database issue", "key": "14_CR14", "doi-asserted-by": "crossref", "first-page": "D439", "DOI": "10.1093/nar/gku1068", "volume": "43", "author": "A Chang", "year": "2015", "unstructured": "Chang A, Schomburg I, Placzek S, Jeske L, Ulbrich M, Xiao M, Sensen CW, Schomburg D (2015) BRENDA in 2015: exciting developments in its 25th year of existence. Nucleic Acids Res 43(Database issue):D439\u2013D446", "journal-title": "Nucleic Acids Res"}, {"issue": "2", "key": "14_CR15", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1021/mp500531e", "volume": "12", "author": "LM Kaminskas", "year": "2015", "unstructured": "Kaminskas LM, McLeod VM, Ascher DB, Ryan GM, Jones S, Haynes JM, Trevaskis NL, Chan LJ, Sloan EK, Finnin BA, Williamson M, Velkov T, Williams ED, Kelly BD, Owen DJ, Porter CJ (2015) Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in rats. Mol Pharm 12(2):432\u2013443", "journal-title": "Mol Pharm"}, {"issue": "7", "key": "14_CR16", "doi-asserted-by": "crossref", "first-page": "2719", "DOI": "10.1021/jm901137j", "volume": "53", "author": "JB Baell", "year": "2010", "unstructured": "Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53(7):2719\u20132740", "journal-title": "J Med Chem"}, {"issue": "Suppl 2", "key": "14_CR17", "doi-asserted-by": "crossref", "first-page": "S14", "DOI": "10.1186/1471-2202-9-S2-S14", "volume": "9", "author": "SY Chai", "year": "2008", "unstructured": "Chai SY, Yeatman HR, Parker MW, Ascher DB, Thompson PE, Mulvey HT, Albiston AL (2008) Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase. BMC Neurosci 9(Suppl 2):S14", "journal-title": "BMC Neurosci"}, {"issue": "13", "key": "14_CR18", "doi-asserted-by": "crossref", "first-page": "2611", "DOI": "10.1021/bi101893w", "volume": "50", "author": "DB Ascher", "year": "2011", "unstructured": "Ascher DB, Cromer BA, Morton CJ, Volitakis I, Cherny RA, Albiston AL, Chai SY, Parker MW (2011) Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain. Biochemistry 50(13):2611\u20132622", "journal-title": "Biochemistry"}, {"issue": "2", "key": "14_CR19", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1002/pro.2604", "volume": "24", "author": "SJ Hermans", "year": "2015", "unstructured": "Hermans SJ, Ascher DB, Hancock NC, Holien JK, Michell BJ, Chai SY, Morton CJ, Parker MW (2015) Crystal structure of human insulin-regulated aminopeptidase with specificity for cyclic peptides. Protein Sci 24(2):190\u2013199", "journal-title": "Protein Sci"}, {"issue": "7", "key": "14_CR20", "doi-asserted-by": "crossref", "first-page": "e0160172", "DOI": "10.1371/journal.pone.0160172", "volume": "11", "author": "AC Silvino", "year": "2016", "unstructured": "Silvino AC, Costa GL, Araujo FC, Ascher DB, Pires DE, Fontes CJ, Carvalho LH, Brito CF, Sousa TN (2016) Variation in human cytochrome P-450 drug-metabolism genes: a gateway to the understanding of plasmodium vivax relapses. PLoS One 11(7):e0160172", "journal-title": "PLoS One"}, {"issue": "28", "key": "14_CR21", "doi-asserted-by": "crossref", "first-page": "7806", "DOI": "10.1002/chem.201100586", "volume": "17", "author": "LJ Parker", "year": "2011", "unstructured": "Parker LJ, Italiano LC, Morton CJ, Hancock NC, Ascher DB, Aitken JB, Harris HH, Campomanes P, Rothlisberger U, De Luca A, Lo Bello M, Ang WH, Dyson PJ, Parker MW (2011) Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activation. Chemistry 17(28):7806\u20137816", "journal-title": "Chemistry"}, {"issue": "2", "key": "14_CR22", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1002/pro.3084", "volume": "26", "author": "LJ Parker", "year": "2017", "unstructured": "Parker LJ, Bocedi A, Ascher DB, Aitken JB, Harris HH, Lo Bello M, Ricci G, Morton CJ, Parker MW (2017) Glutathione transferase P1-1 as an arsenic drug-sequestering enzyme. Protein Sci 26(2):317\u2013326", "journal-title": "Protein Sci"}, {"issue": "3", "key": "14_CR23", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1016/j.jmb.2016.12.004", "volume": "429", "author": "HC Jubb", "year": "2017", "unstructured": "Jubb HC, Higueruelo AP, Ochoa-Montano B, Pitt WR, Ascher DB, Blundell TL (2017) Arpeggio: a web server for calculating and visualising interatomic interactions in protein structures. J Mol Biol 429(3):365\u2013371", "journal-title": "J Mol Biol"}, {"key": "14_CR24", "doi-asserted-by": "crossref", "first-page": "29575", "DOI": "10.1038/srep29575", "volume": "6", "author": "DE Pires", "year": "2016", "unstructured": "Pires DE, Blundell TL, Ascher DB (2016) mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance. Sci Rep 6:29575", "journal-title": "Sci Rep"}, {"issue": "Database issue", "key": "14_CR25", "doi-asserted-by": "crossref", "first-page": "D387", "DOI": "10.1093/nar/gku966", "volume": "43", "author": "DE Pires", "year": "2015", "unstructured": "Pires DE, Blundell TL, Ascher DB (2015) Platinum: a database of experimentally measured effects of mutations on structurally defined protein-ligand complexes. Nucleic Acids Res 43(Database issue):D387\u2013D391", "journal-title": "Nucleic Acids Res"}, {"key": "14_CR26", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1186/s12916-016-0575-9", "volume": "14", "author": "J Phelan", "year": "2016", "unstructured": "Phelan J, Coll F, McNerney R, Ascher DB, Pires DE, Furnham N, Coeck N, Hill-Cawthorne GA, Nair MB, Mallard K, Ramsay A, Campino S, Hibberd ML, Pain A, Rigouts L, Clark TG (2016) Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. BMC Med 14:31", "journal-title": "BMC Med"}, {"issue": "1", "key": "14_CR27", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.1021/acsinfecdis.6b00102", "volume": "3", "author": "V Singh", "year": "2016", "unstructured": "Singh V, Donini S, Pacitto A, Sala C, Hartkoorn RC, Dhar N, Keri G, Ascher DB, Mond\u00e9sert G, Vocat A, Lupien A, Sommer R, Vermet H, Lagrange S, Buechler J, Warner DF, McKinney JD, Pato J, Cole ST, Blundell TL, Rizzi M, Mizrahi V (2016) The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis. ACS Infect Dis 3(1):5\u201317. \nhttps://doi.org/10.1021/acsinfecdis.6b00102", "journal-title": "ACS Infect Dis"}, {"issue": "3", "key": "14_CR28", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1093/bioinformatics/btt691", "volume": "30", "author": "DE Pires", "year": "2014", "unstructured": "Pires DE, Ascher DB, Blundell TL (2014) mCSM: predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics 30(3):335\u2013342", "journal-title": "Bioinformatics"}, {"issue": "Web Server issu", "key": "14_CR29", "doi-asserted-by": "crossref", "first-page": "W314", "DOI": "10.1093/nar/gku411", "volume": "42", "author": "DE Pires", "year": "2014", "unstructured": "Pires DE, Ascher DB, Blundell TL (2014) DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res 42(Web Server issue):W314\u2013W319", "journal-title": "Nucleic Acids Res"}, {"issue": "2", "key": "14_CR30", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1042/BST20160422", "volume": "45", "author": "AP Pandurangan", "year": "2017", "unstructured": "Pandurangan AP, Ascher DB, Thomas SE, Blundell TL (2017) Genomes, structural biology, and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance. Biochem Soc Trans 45(2):303\u2013311", "journal-title": "Biochem Soc Trans"}, {"issue": "Web Server issu", "key": "14_CR31", "doi-asserted-by": "publisher", "first-page": "W215", "DOI": "10.1093/nar/gkx439", "volume": "39", "author": "AP Pandurangan", "year": "2017", "unstructured": "Pandurangan AP, Ochoa-Monta\u00f1o B, Ascher DB, Blundell TL (2017) SDM: a server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res 39(Web Server issue):W215\u2013W222. \nhttps://doi.org/10.1093/nar/gkx439", "journal-title": "Nucleic Acids Res"}, {"key": "14_CR32", "doi-asserted-by": "crossref", "first-page": "19848", "DOI": "10.1038/srep19848", "volume": "6", "author": "DE Pires", "year": "2016", "unstructured": "Pires DE, Chen J, Blundell TL, Ascher DB (2016) In silico functional dissection of saturation mutagenesis: interpreting the relationship between phenotypes and changes in protein stability, interactions and activity. Sci Rep 6:19848", "journal-title": "Sci Rep"}, {"key": "14_CR33", "author": "DB Ascher", "first-page": "141", "year": "2015", "unstructured": "Ascher DB, Jubb HC, Pires DEV, Ochi T, Higueruelo A, Blundell TL (2015) Protein-protein interactions: structures and druggability. In: Scapin G, Patel D, Arnold E (eds) Multifaceted roles of crystallography in modern drug discovery. Springer Netherlands, Dordrecht, pp 141\u2013163", "volume-title": "Multifaceted roles of crystallography in modern drug discovery"}, {"issue": "1", "key": "14_CR34", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1016/j.pbiomolbio.2015.01.009", "volume": "119", "author": "H Jubb", "year": "2015", "unstructured": "Jubb H, Blundell TL, Ascher DB (2015) Flexibility and small pockets at protein-protein interfaces: new insights into druggability. Prog Biophys Mol Biol 119(1):2\u20139", "journal-title": "Prog Biophys Mol Biol"}, {"key": "14_CR35", "unstructured": "Pires DE, Ascher DB (2017) mCSM-NA: predicting the effects of mutations on protein-nucleic acids interactions. Nucleic Acids Res. \nhttps://doi.org/10.1093/nar/gkx236", "DOI": "10.1093/nar/gkx236", "doi-asserted-by": "crossref"}, {"issue": "W1", "key": "14_CR36", "doi-asserted-by": "crossref", "first-page": "W469", "DOI": "10.1093/nar/gkw458", "volume": "44", "author": "DE Pires", "year": "2016", "unstructured": "Pires DE, Ascher DB (2016) mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signatures. Nucleic Acids Res 44(W1):W469\u2013W473", "journal-title": "Nucleic Acids Res"}, {"key": "14_CR37", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1016/j.pbiomolbio.2016.10.002", "volume": "128", "author": "HC Jubb", "year": "2017", "unstructured": "Jubb HC, Pandurangan AP, Turner MA, Ochoa-Montano B, Blundell TL, Ascher DB (2017) Mutations at protein-protein interfaces: small changes over big surfaces have large impacts on human health. Prog Biophys Mol Biol 128:3\u201313. \nhttps://doi.org/10.1016/j.pbiomolbio.2016.10.002", "journal-title": "Prog Biophys Mol Biol"}], "container-title": ["Methods in Molecular Biology", "Computational Drug Discovery and Design"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-7756-7_14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 3, 28]], "date-time": "2018-03-28T13:15:03Z", "timestamp": 1522242903000}, "score": 16.14017, "issued": {"date-parts": [[2018]]}, "ISBN": ["9781493977550", "9781493977567"], "references-count": 37, "URL": "http://dx.doi.org/10.1007/978-1-4939-7756-7_14", "relation": {"cites": []}, "ISSN": ["1064-3745", "1940-6029"], "issn-type": [{"value": "1064-3745", "type": "print"}, {"value": "1940-6029", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T09:07:18Z", "timestamp": 1575364038728}, "reference-count": 65, "publisher": "Bentham Science Publishers Ltd.", "issue": "42", "content-domain": {"domain": ["eurekaselect.com"], "crossmark-restriction": true}, "short-container-title": ["CPD"], "published-print": {"date-parts": [[2019, 3, 20]]}, "abstract": "<jats:sec>\n<jats:title>Background:</jats:title>\n<jats:p>Pulmonary diseases are the third leading cause of morbidity worldwide, however treatment\nand diagnosis of these diseases continue to be challenging due to the complex anatomical structure as well\nas physiological processes in the lungs.</jats:p></jats:sec>\n<jats:sec>\n<jats:title>Methods:</jats:title>\n<jats:p>\n 3D printing is progressively finding new avenues in the medical field and this technology is constantly\nbeing used for diseases where diagnosis and treatment heavily rely on the thorough understanding of complex\nstructural-physiology relationships. The structural and functional complexity of the pulmonary system makes it\nwell suited to 3D printing technology.</jats:p></jats:sec>\n<jats:sec>\n<jats:title>Results:</jats:title>\n<jats:p> 3D printing can be used to deconstruct the complex anatomy of the lungs and improve our understanding\nof its physiological mechanisms, cell interactions and pathophysiology of pulmonary diseases. Thus, this technology\ncan be quite helpful in the discovery of novel therapeutic targets, new drugs and devices for the treatment of\nlung diseases.</jats:p></jats:sec>\n<jats:sec>\n<jats:title>Conclusion: </jats:title>\n<jats:p>The intention of this review is to detail our current understanding of the applications of 3D printing\nin the design and evaluation of inhalable medicines and to provide an overview on its application in the diagnosis\nand treatment of pulmonary diseases. This review also discusses other technical and regulatory challenges associated\nwith the progression of 3D printing into clinical practice.</jats:p></jats:sec>", "DOI": "10.2174/1381612825666181206123414", "type": "journal-article", "created": {"date-parts": [[2018, 12, 7]], "date-time": "2018-12-07T11:07:20Z", "timestamp": 1544180840000}, "page": "5072-5080", "update-policy": "http://dx.doi.org/10.2174/bsp_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Applications of 3D Printing in Pulmonary Drug Delivery and Treatment of Respiratory Disorders"], "prefix": "10.2174", "volume": "24", "author": [{"given": "Shadabul", "family": "Haque", "sequence": "first", "affiliation": [{"name": "Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, Parkville VIC, Australia"}]}, {"given": "Shadab", "family": "Md", "sequence": "additional", "affiliation": [{"name": "Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22252, Saudi Arabia"}]}, {"given": "Michael", "family": "Whittaker", "sequence": "additional", "affiliation": [{"name": "Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, Parkville VIC, Australia"}]}, {"given": "Lisa M.", "family": "Kaminskas", "sequence": "additional", "affiliation": [{"name": "Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, Parkville VIC, Australia"}]}], "member": "965", "reference": [{"key": "ref=1", "author": "Mueller B.", "volume": "32", "year": "2012", "unstructured": "Mueller B.  Additive manufacturing technologies\u2013Rapid prototyping to direct digital manufacturing.", "journal-title": "Assem Autom", "DOI": "10.1108/aa.2012.03332baa.010", "doi-asserted-by": "crossref"}, {"key": "ref=2", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1016/S0007-8506(07)60206-6", "volume": "52", "author": "Levy G.N.", "year": "2003", "unstructured": "Levy GN, Schindel R, Kruth J-P.  Rapid manufacturing and rapid tooling with layer manufacturing (LM) technologies, state of the art and future perspectives.", "journal-title": "CIRP Annals-Manufacturing Technology"}, {"key": "ref=3", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/j.bushor.2011.11.003", "volume": "55", "author": "Berman B.", "year": "2012", "unstructured": "Berman B.  3-D printing: The new industrial revolution.", "journal-title": "Bus Horiz"}, {"key": "ref=4", "doi-asserted-by": "crossref", "first-page": "1006", "DOI": "10.1016/j.joms.2005.03.016", "volume": "63", "author": "Winder J.", "year": "2005", "unstructured": "Winder J, Bibb R.  Medical rapid prototyping technologies: state of the art and current limitations for application in oral and maxillofacial surgery.", "journal-title": "J Oral Maxillofac Surg"}, {"key": "ref=5", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1243/0954411981534150", "volume": "212", "author": "Potamianos P.", "year": "1998", "unstructured": "Potamianos P, Amis AA, Forester AJ, McGurk M, Bircher M.  Rapid prototyping for orthopaedic surgery.", "journal-title": "Proc Inst Mech Eng H"}, {"key": "ref=6", "doi-asserted-by": "crossref", "first-page": "512", "DOI": "10.1016/j.jss.2015.06.051", "volume": "199", "author": "Malik H.H.", "year": "2015", "unstructured": "Malik HH, Darwood AR, Shaunak S.  Three-dimensional printing in surgery: A review of current surgical applications.", "journal-title": "J Surg Res"}, {"key": "ref=7", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.3109/10929080009148886", "volume": "5", "author": "Bettega G.", "year": "2000", "unstructured": "Bettega G, Payan Y, Mollard B, Boyer A, Rapha\u00ebl B, Lavall\u00e9e S.  A simulator for maxillofacial surgery integrating 3D cephalometry and orthodontia.", "journal-title": "Comput Aided Surg"}, {"key": "ref=8", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.5306/wjco.v8.i1.21", "volume": "8", "author": "Charbe N.", "year": "2017", "unstructured": "Charbe N, McCarron PA, Tambuwala MM.  Three-dimensional bio-printing: A new frontier in oncology research.", "journal-title": "World J Clin Oncol"}, {"key": "ref=9", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1038/nbt.2958", "volume": "32", "author": "Murphy S.V.", "year": "2014", "unstructured": "Murphy SV, Atala A.  3D bioprinting of tissues and organs.", "journal-title": "Nat Biotechnol"}, {"key": "ref=10", "doi-asserted-by": "crossref", "first-page": "3265", "DOI": "10.1089/ten.2006.12.3265", "volume": "12", "author": "Ingber D.E.", "year": "2006", "unstructured": "Ingber DE, Mow VC, Butler D.  Tissue engineering and developmental biology: going biomimetic.", "journal-title": "Tissue Eng"}, {"key": "ref=11", "doi-asserted-by": "crossref", "first-page": "2541", "DOI": "10.1242/dev.003707", "volume": "134", "author": "Ingber D.E.", "year": "2007", "unstructured": "Ingber DE, Levin M.  What lies at the interface of regenerative medicine and developmental biology?", "journal-title": "Development"}, {"key": "ref=12", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1016/j.tips.2018.02.006", "volume": "39", "author": "Trenfield S.J.", "year": "2018", "unstructured": "Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW.  3D Printing Pharmaceuticals: Drug Development to Frontline Care.", "journal-title": "Trends Pharmacol Sci"}, {"key": "ref=13", "doi-asserted-by": "crossref", "first-page": "4", "DOI": "10.1186/s13036-015-0001-4", "volume": "9", "author": "Chia H.N.", "year": "2015", "unstructured": "Chia HN, Wu BM.  Recent advances in 3D printing of biomaterials.", "journal-title": "J Biol Eng"}, {"key": "ref=14", "doi-asserted-by": "crossref", "first-page": "518", "DOI": "10.1038/nmat1421", "volume": "4", "author": "Hollister S.J.", "year": "2005", "unstructured": "Hollister SJ.  Porous scaffold design for tissue engineering.", "journal-title": "Nat Mater"}, {"key": "ref=15", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/j.ejpb.2014.12.003", "volume": "89", "author": "Goyanes A.", "year": "2015", "unstructured": "Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW.  3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.", "journal-title": "Eur J Pharm Biopharm"}, {"key": "ref=16", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1007/s11095-018-2454-x", "volume": "35", "author": "Jamr\u00f3z W.", "year": "2018", "unstructured": "Jamr\u00f3z W, Szafraniec J, Kurek M, Jachowicz R.  3D Printing in Pharmaceutical and Medical Applications - Recent Achievements and Challenges.", "journal-title": "Pharm Res"}, {"key": "ref=17", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1016/j.ijpharm.2018.07.024", "volume": "548", "author": "Awad A.", "year": "2018", "unstructured": "Awad A, Trenfield SJ, Gaisford S, Basit AW.  3D printed medicines: A new branch of digital healthcare.", "journal-title": "Int J Pharm"}, {"key": "ref=18", "doi-asserted-by": "crossref", "first-page": "1965", "DOI": "10.1148/rg.2015140320", "volume": "35", "author": "Mitsouras D.", "year": "2015", "unstructured": "Mitsouras D, Liacouras P, Imanzadeh A.  Medical 3D printing for the radiologist.", "journal-title": "Radiographics"}, {"key": "ref=19", "first-page": "169", "volume": "79", "author": "McGurk M.", "year": "1997", "unstructured": "McGurk M, Amis AA, Potamianos P, Goodger NM.  Rapid prototyping techniques for anatomical modelling in medicine.", "journal-title": "Ann R Coll Surg Engl"}, {"key": "ref=20", "doi-asserted-by": "crossref", "first-page": "1136", "DOI": "10.1016/j.chest.2016.03.001", "volume": "149", "author": "Cheng G.Z.", "year": "2016", "unstructured": "Cheng GZ, San Jose Estepar R, Folch E, Onieva J, Gangadharan S, Majid A.  Three-dimensional printing and 3D slicer: powerful tools in understanding and treating structural lung disease.", "journal-title": "Chest"}, {"key": "ref=21", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1038/nbt.2958", "volume": "32", "author": "Murphy S.V.", "year": "2014", "unstructured": "Murphy SV, Atala A.  3D bioprinting of tissues and organs.", "journal-title": "Nat Biotechnol"}, {"key": "ref=22", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/0169-409X(95)00113-L", "volume": "19", "author": "Patton J.S.", "year": "1996", "unstructured": "Patton JS.  Mechanisms of macromolecule absorption by the lungs.", "journal-title": "Adv Drug Deliv Rev"}, {"key": "ref=23", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1038/nrd2153", "volume": "6", "author": "Patton J.S.", "year": "2007", "unstructured": "Patton JS, Byron PR.  Inhaling medicines: delivering drugs to the body through the lungs.", "journal-title": "Nat Rev Drug Discov"}, {"key": "ref=24", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1513/pats.200409-049TA", "volume": "1", "author": "Patton J.S.", "year": "2004", "unstructured": "Patton JS, Fishburn CS, Weers JG.  The lungs as a portal of entry for systemic drug delivery.", "journal-title": "Proc Am Thorac Soc"}, {"key": "ref=25", "doi-asserted-by": "crossref", "first-page": "1703", "DOI": "10.1016/j.nano.2016.03.002", "volume": "12", "author": "Haque S.", "year": "2016", "unstructured": "Haque S, Whittaker MR, McIntosh MP, Pouton CW, Kaminskas LM.  Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges.", "journal-title": "Nanomedicine (Lond)"}, {"key": "ref=26", "doi-asserted-by": "crossref", "first-page": "404", "DOI": "10.1513/AnnalsATS.201311-405PS", "volume": "11", "author": "Ferkol T.", "year": "2014", "unstructured": "Ferkol T, Schraufnagel D.  The global burden of respiratory disease.", "journal-title": "Ann Am Thorac Soc"}, {"key": "ref=27", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1513/AnnalsATS.201312-420PS", "volume": "11", "author": "Schluger N.W.", "year": "2014", "unstructured": "Schluger NW, Koppaka R.  Lung disease in a global context. A call for public health action.", "journal-title": "Ann Am Thorac Soc"}, {"key": "ref=28", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/j.addr.2014.05.014", "volume": "75", "author": "de Souza Carvalho C.", "year": "2014", "unstructured": "de Souza Carvalho C, Daum N, Lehr C-M.  Carrier interactions with the biological barriers of the lung: Advanced  models and challenges for pulmonary drug delivery.", "journal-title": "Adv Drug Deliv Rev"}, {"key": "ref=29", "doi-asserted-by": "crossref", "first-page": "2457", "DOI": "10.2217/nnm-2016-0199", "volume": "11", "author": "Fytianos K.", "year": "2016", "unstructured": "Fytianos K, Drasler B, Blank F.  Current  approaches to assess nanoparticle interactions with lung cells.", "journal-title": "Nanomedicine (Lond)"}, {"key": "ref=30", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1016/j.cocis.2017.06.003", "volume": "31", "author": "Marasini N.", "year": "2017", "unstructured": "Marasini N, Haque S, Kaminskas LM.  Polymer-drug conjugates as inhalable drug delivery systems: A review.", "journal-title": "Curr Opin Colloid Interface Sci"}, {"key": "ref=31", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1089/jam.2005.18.137", "volume": "18", "author": "Steimer A.", "year": "2005", "unstructured": "Steimer A, Haltner E, Lehr C-M.  Cell culture models of the respiratory tract relevant to pulmonary drug delivery.", "journal-title": "J Aerosol Med"}, {"key": "ref=32", "doi-asserted-by": "crossref", "first-page": "736", "DOI": "10.1038/labinvest.3700081", "volume": "84", "author": "Hermanns M.I.", "year": "2004", "unstructured": "Hermanns MI, Unger RE, Kehe K, Peters K, Kirkpatrick CJ.  Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier", "journal-title": "Lab Invest"}, {"key": "ref=33", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1186/1743-8977-10-31", "volume": "10", "author": "Klein S.G.", "year": "2013", "unstructured": "Klein SG, Serchi T, Hoffmann L, Bl\u00f6meke B, Gutleb AC.  An improved 3D tetraculture system mimicking the cellular organisation at the alveolar barrier to study the potential toxic effects of particles on the lung.", "journal-title": "Part Fibre Toxicol"}, {"key": "ref=34", "doi-asserted-by": "crossref", "first-page": "7974", "DOI": "10.1038/srep07974", "volume": "5", "author": "Horv\u00e1th L.", "year": "2015", "unstructured": "Horv\u00e1th L, Umehara Y, Jud C, Blank F, Petri-Fink A, Rothen-Rutishauser B.  Engineering an  air-blood barrier by 3D bioprinting.", "journal-title": "Sci Rep"}, {"key": "ref=35", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1016/0034-5687(78)90104-4", "volume": "32", "author": "Gehr P.", "year": "1978", "unstructured": "Gehr P, Bachofen M, Weibel ER.  The normal human lung: ultrastructure and morphometric estimation of diffusion capacity.", "journal-title": "Respir Physiol"}, {"key": "ref=36", "first-page": "375", "volume": "139", "author": "Weibel E.R.", "year": "2009", "unstructured": "Weibel ER.  What makes a good lung?", "journal-title": "Swiss Med Wkly"}, {"key": "ref=37", "doi-asserted-by": "crossref", "first-page": "2135", "DOI": "10.1038/nprot.2013.137", "volume": "8", "author": "Huh D.", "year": "2013", "unstructured": "Huh D, Kim HJ, Fraser JP.  Microfabrication of human organs-on-chips.", "journal-title": "Nat Protoc"}, {"key": "ref=38", "author": "Huh D", "year": "", "unstructured": "Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA."}, {"key": "ref=39", "doi-asserted-by": "crossref", "first-page": "1662", "DOI": "10.1126/science.1188302", "volume": "328", "author": "Huh D.", "year": "2010", "unstructured": "Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE.  Reconstituting organ-level lung functions on a chip.", "journal-title": "Science"}, {"key": "ref=40", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.3390/bioengineering4010010", "volume": "4", "author": "Yi H-G.", "year": "2017", "unstructured": "Yi H-G, Lee H, Cho D-W.  3D printing of organs-on-chips.", "journal-title": "Bioengineering (Basel)"}, {"key": "ref=41", "doi-asserted-by": "crossref", "first-page": "790", "DOI": "10.1096/fj.06-7117com", "volume": "21", "author": "Liu Tsang V.", "year": "2007", "unstructured": "Liu Tsang V, Chen AA, Cho LM.  Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels.", "journal-title": "FASEB J"}, {"key": "ref=42", "doi-asserted-by": "crossref", "first-page": "034112", "DOI": "10.1088/1758-5082/3/3/034112", "volume": "3", "author": "Snyder J.E.", "year": "2011", "unstructured": "Snyder JE, Hamid Q, Wang C.  Bioprinting cell-laden matrigel for radioprotection study of liver by pro-drug conversion in a dual-tissue microfluidic chip.", "journal-title": "Biofabrication"}, {"key": "ref=43", "doi-asserted-by": "crossref", "first-page": "035005", "DOI": "10.1088/1758-5082/4/3/035005", "volume": "4", "author": "Hockaday L.A.", "year": "2012", "unstructured": "Hockaday LA, Kang KH, Colangelo NW.  Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds.", "journal-title": "Biofabrication"}, {"key": "ref=44", "doi-asserted-by": "crossref", "first-page": "490", "DOI": "10.1148/radiol.2422051994", "volume": "242", "author": "Schievano S.", "year": "2007", "unstructured": "Schievano S, Migliavacca F, Coats L.  Percutaneous pulmonary valve implantation based on rapid prototyping of right ventricular outflow tract and pulmonary trunk from MR data.", "journal-title": "Radiology"}, {"key": "ref=45", "doi-asserted-by": "crossref", "first-page": "015002", "DOI": "10.1088/1758-5090/aae545", "volume": "11", "author": "Park J.Y.", "year": "2018", "unstructured": "Park JY, Ryu H, Lee B.  Development of a functional airway-on-a-chip by 3D cell printing.", "journal-title": "Biofabrication"}, {"key": "ref=46", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/j.tibtech.2007.09.005", "volume": "25", "author": "Sung J.C.", "year": "2007", "unstructured": "Sung JC, Pulliam BL, Edwards DA.  Nanoparticles for drug delivery to the lungs.", "journal-title": "Trends Biotechnol"}, {"key": "ref=47", "first-page": "440", "volume": "23", "author": "Shadab M.", "year": "2017", "unstructured": "Shadab M, Haque S, Sheshala R, Meng LW, Meka VS, Ali J.  Recent advances in non-invasive delivery of macromolecules using nanoparticulate carriers system.", "journal-title": "Curr Pharm Des"}, {"key": "ref=48", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.2174/1573413714666180313130235", "volume": "14", "author": "Shadabul H.", "year": "2018", "unstructured": "Shadabul H, Ben JB, Michelle PM, Colin WP, Lisa MK, Michael W.  Suggested Procedures for the Reproducible Synthesis of Poly(d,l-lactideco-glycolide) Nanoparticles Using the Emulsification Solvent Diffusion Platform.", "journal-title": "Curr Nanosci"}, {"key": "ref=49", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1016/j.ejpb.2017.07.005", "volume": "119", "author": "Haque S.", "year": "2017", "unstructured": "Haque S, McLeod VM, Jones S.  Effect of increased surface hydrophobicity via drug conjugation on the clearance of inhaled PEGylated polylysine dendrimers.", "journal-title": "Eur J Pharm Biopharm"}, {"key": "ref=50", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.ejpb.2018.01.001", "volume": "125", "author": "Haque S.", "year": "2018", "unstructured": "Haque S, Whittaker M, McIntosh MP, Pouton CW, Phipps S, Kaminskas LM.  A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the H-labelled structural lipids after pulmonary delivery in rats.", "journal-title": "Eur J Pharm Biopharm"}, {"key": "ref=51", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.2174/1573413714666180313130235", "volume": "14", "author": "Haque S.", "year": "2018", "unstructured": "Haque S, Boyd BJ, McIntosh MP, Pouton CW, Kaminskas LM, Whittaker M.  Suggested Procedures for the Reproducible Synthesis of Poly (d, l-lactide-co-glycolide) Nanoparticles Using the Emulsification Solvent Diffusion Platform.", "journal-title": "Curr Nanosci"}, {"key": "ref=52", "doi-asserted-by": "crossref", "first-page": "1601355", "DOI": "10.1183/13993003.01355-2016", "volume": "52", "author": "De Santis M.M.", "year": "2018", "unstructured": "De Santis MM, B\u00f6l\u00fckbas DA, Lindstedt S, Wagner DE.  How to build a lung: latest advances and emerging themes in lung bioengineering.", "journal-title": "Eur Respir J"}, {"key": "ref=53", "author": "Morrison RJ", "year": "", "unstructured": "Morrison RJ, Hollister SJ, Niedner MF, Mahani MG, Park AH, Mehta DK."}, {"key": "ref=54", "doi-asserted-by": "crossref", "first-page": "66", "DOI": "10.1001/jamaoto.2013.5644", "volume": "140", "author": "Zopf D.A.", "year": "2014", "unstructured": "Zopf DA, Flanagan CL, Wheeler M, Hollister SJ, Green GE.  Treatment of severe porcine tracheomalacia with a 3-dimensionally printed, bioresorbable, external airway splint.", "journal-title": "JAMA Otolaryngol Head Neck Surg"}, {"key": "ref=55", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1002/lary.26213", "volume": "127", "author": "Kaye R.", "year": "2017", "unstructured": "Kaye R, Goldstein T, Aronowitz D, Grande DA, Zeltsman D, Smith LP.  Ex vivo tracheomalacia model with 3D-printed external tracheal splint.", "journal-title": "Laryngoscope"}, {"key": "ref=56", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1164/rccm.200602-163OC", "volume": "174", "author": "Raghu G.", "year": "2006", "unstructured": "Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G.  Incidence and prevalence of idiopathic pulmonary fibrosis.", "journal-title": "Am J Respir Crit Care Med"}, {"key": "ref=57", "doi-asserted-by": "crossref", "first-page": "S4", "DOI": "10.1016/j.jpeds.2016.09.064", "volume": "181", "author": "Farrell P.M.", "year": "2017", "unstructured": "Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N.  Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation.", "journal-title": "J Pediatr"}, {"key": "ref=58", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1186/s12931-014-0084-3", "volume": "15", "author": "Kim V.", "year": "2014", "unstructured": "Kim V, Desai P, Newell JD.  Airway wall thickness is increased in COPD patients with bronchodilator responsiveness.", "journal-title": "Respir Res"}, {"key": "ref=59", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1186/1471-2458-12-204", "volume": "12", "author": "To T.", "year": "2012", "unstructured": "To T, Stanojevic S, Moores G.  Global asthma prevalence in adults: findings from the cross-sectional world health survey.", "journal-title": "BMC Public Health"}, {"key": "ref=60", "doi-asserted-by": "crossref", "first-page": "926", "DOI": "10.1016/j.jaci.2010.07.019", "volume": "126", "author": "Bousquet J.", "year": "2010", "unstructured": "Bousquet J, Mantzouranis E, Cruz AA.  Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma.", "journal-title": "J Allergy Clin Immunol"}, {"key": "ref=61", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.3390/ma11081317", "volume": "11", "author": "Qui\u00f1ones D.R.", "year": "2018", "unstructured": "Qui\u00f1ones DR, Soler-Egea D, Gonz\u00e1lez-P\u00e9rez V.  Open Source 3D Printed Lung Tumor Movement Simulator for Radiotherapy Quality Assurance.", "journal-title": "Materials (Basel)"}, {"key": "ref=62", "doi-asserted-by": "crossref", "first-page": "3529", "DOI": "10.1038/srep03529", "volume": "3", "author": "Velazquez E.R.", "year": "2013", "unstructured": "Velazquez ER, Parmar C, Jermoumi M.  Volumetric CT-based segmentation of NSCLC using 3D-Slicer.", "journal-title": "Sci Rep"}, {"key": "ref=63", "first-page": "w13758", "volume": "143", "author": "Jud C.", "year": "2013", "unstructured": "Jud C, Clift MJ, Petri-Fink A, Rothen-Rutishauser B.  Nanomaterials and the human lung: what is known and what must be deciphered to realise their potential advantages?", "journal-title": "Swiss Med Wkly"}, {"key": "ref=64", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1080/15287398509530647", "volume": "15", "author": "Schlesinger R.B.", "year": "1985", "unstructured": "Schlesinger RB.  Comparative deposition of inhaled aerosols in experimental animals and humans: A review.", "journal-title": "J Toxicol Environ Health"}, {"key": "ref=65", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1016/j.addr.2007.08.023", "volume": "59", "author": "Cryan S-A.", "year": "2007", "unstructured": "Cryan S-A, Sivadas N, Garcia-Contreras L.  \n animal models for drug delivery across the lung mucosal barrier.", "journal-title": "Adv Drug Deliv Rev"}], "container-title": ["Current Pharmaceutical Design"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/168124", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 20]], "date-time": "2019-04-20T19:03:10Z", "timestamp": 1555786990000}, "score": 16.14017, "issued": {"date-parts": [[2019, 3, 20]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[2019, 3, 20]]}, "issue": "42"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/1381612825666181206123414", "relation": {"cites": []}, "ISSN": ["1381-6128"], "issn-type": [{"value": "1381-6128", "type": "print"}], "subject": ["Pharmacology", "Drug Discovery"], "assertion": [{"value": "Peer Reviewed", "order": 0, "name": "review_status", "label": "Review Status", "group": {"name": "peer_review_details", "label": "Peer Review Details"}}, {"value": "Single blind", "order": 1, "name": "review_process", "label": "Review Process", "group": {"name": "peer_review_details", "label": "Peer Review Details"}}, {"value": "Checked with iThenticate", "order": 0, "name": "screening_status", "label": "Screening Status", "group": {"name": "plagiarism_screening", "label": "Plagiarism Screening"}}, {"value": "2018-11-01", "order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-11-28", "order": 1, "name": "revised", "label": "Revised", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-12-04", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2019-03-20", "order": 3, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T14:51:57Z", "timestamp": 1575471117147}, "reference-count": 195, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 11, 1]], "date-time": "2014-11-01T00:00:00Z", "timestamp": 1414800000000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100000925", "name": "National Health and Medical Research Council", "doi-asserted-by": "publisher", "award": []}, {"DOI": "10.13039/501100000951", "name": "Cancer Council Victoria", "doi-asserted-by": "crossref", "award": []}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Controlled Release"], "published-print": {"date-parts": [[2014, 11]]}, "DOI": "10.1016/j.jconrel.2014.04.051", "type": "journal-article", "created": {"date-parts": [[2014, 5, 5]], "date-time": "2014-05-05T00:46:19Z", "timestamp": 1399250779000}, "page": "241-256", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 37, "title": ["Nano-chemotherapeutics: Maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers"], "prefix": "10.1016", "volume": "193", "author": [{"given": "Gemma M.", "family": "Ryan", "sequence": "first", "affiliation": []}, {"given": "Lisa M.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0003-3474-7551", "authenticated-orcid": false, "given": "Christopher J.H.", "family": "Porter", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Controlled Release"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0168365914002843?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0168365914002843?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 10]], "date-time": "2019-08-10T03:08:35Z", "timestamp": 1565406515000}, "score": 16.14017, "issued": {"date-parts": [[2014, 11]]}, "references-count": 195, "alternative-id": ["S0168365914002843"], "URL": "http://dx.doi.org/10.1016/j.jconrel.2014.04.051", "ISSN": ["0168-3659"], "issn-type": [{"value": "0168-3659", "type": "print"}], "subject": ["Pharmaceutical Science"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Nano-chemotherapeutics: Maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Controlled Release", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jconrel.2014.04.051", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T10:17:06Z", "timestamp": 1574590626340}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2015, 6, 15]]}, "DOI": "10.1158/1078-0432.ccr-14-3119", "type": "journal-article", "created": {"date-parts": [[2015, 3, 24]], "date-time": "2015-03-24T02:23:33Z", "timestamp": 1427163813000}, "page": "2666-2670", "source": "Crossref", "is-referenced-by-count": 107, "title": ["FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma"], "prefix": "10.1158", "volume": "21", "author": [{"given": "H.-Z.", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "V. E.", "family": "Kwitkowski", "sequence": "additional", "affiliation": []}, {"given": "P. L.", "family": "Del Valle", "sequence": "additional", "affiliation": []}, {"given": "M. S.", "family": "Ricci", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Saber", "sequence": "additional", "affiliation": []}, {"given": "B. A.", "family": "Habtemariam", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Bullock", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Bloomquist", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Li Shen", "sequence": "additional", "affiliation": []}, {"given": "X.-H.", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Brown", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Mehrotra", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Dorff", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Charlab", "sequence": "additional", "affiliation": []}, {"given": "R. C.", "family": "Kane", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Justice", "sequence": "additional", "affiliation": []}, {"given": "A. T.", "family": "Farrell", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Pazdur", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2015, 3, 23]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-14-3119", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T12:01:12Z", "timestamp": 1482494472000}, "score": 14.216723, "issued": {"date-parts": [[2015, 3, 23]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 6, 14]]}, "published-print": {"date-parts": [[2015, 6, 15]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-14-3119", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T11:23:26Z", "timestamp": 1576841006258}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2015, 4, 1]]}, "DOI": "10.1158/1078-0432.ccr-14-2522", "type": "journal-article", "created": {"date-parts": [[2015, 2, 3]], "date-time": "2015-02-03T05:14:26Z", "timestamp": 1422940466000}, "page": "1525-1529", "source": "Crossref", "is-referenced-by-count": 52, "title": ["FDA Approval: Idelalisib Monotherapy for the Treatment of Patients with Follicular Lymphoma and Small Lymphocytic Lymphoma"], "prefix": "10.1158", "volume": "21", "author": [{"given": "B. W.", "family": "Miller", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Przepiorka", "sequence": "additional", "affiliation": []}, {"given": "R. A.", "family": "de Claro", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Nie", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Simpson", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Gudi", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Saber", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Shord", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Bullock", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Marathe", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Mehrotra", "sequence": "additional", "affiliation": []}, {"given": "L. S.", "family": "Hsieh", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Ghosh", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Brown", "sequence": "additional", "affiliation": []}, {"given": "R. C.", "family": "Kane", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Justice", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "A. T.", "family": "Farrell", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Pazdur", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2015, 2, 2]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-14-2522", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T03:31:34Z", "timestamp": 1482463894000}, "score": 14.216723, "issued": {"date-parts": [[2015, 2, 2]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 3, 31]]}, "published-print": {"date-parts": [[2015, 4, 1]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-14-2522", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T08:34:26Z", "timestamp": 1574584466673}, "reference-count": 42, "publisher": "Mary Ann Liebert Inc", "issue": "5", "license": [{"URL": "http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/", "start": {"date-parts": [[2015, 10, 1]], "date-time": "2015-10-01T00:00:00Z", "timestamp": 1443657600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Aerosol Medicine and Pulmonary Drug Delivery"], "published-print": {"date-parts": [[2015, 10]]}, "DOI": "10.1089/jamp.2014.1176", "type": "journal-article", "created": {"date-parts": [[2015, 2, 25]], "date-time": "2015-02-25T14:58:27Z", "timestamp": 1424876307000}, "page": "361-371", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration"], "prefix": "10.1089", "volume": "28", "author": [{"given": "Tom\u00e1s", "family": "Sou", "sequence": "first", "affiliation": [{"name": "Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia."}]}, {"given": "David A.V.", "family": "Morton", "sequence": "additional", "affiliation": [{"name": "Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia."}]}, {"given": "Mark", "family": "Williamson", "sequence": "additional", "affiliation": [{"name": "Gribbles Veterinary Pathology, Clayton, Victoria, Australia."}]}, {"given": "Els N.", "family": "Meeusen", "sequence": "additional", "affiliation": [{"name": "Department of Microbiology and ARC Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton, Victoria, Australia."}]}, {"given": "Lisa M.", "family": "Kaminskas", "sequence": "additional", "affiliation": [{"name": "Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia."}]}, {"given": "Michelle P.", "family": "McIntosh", "sequence": "additional", "affiliation": [{"name": "Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia."}]}], "member": "278", "container-title": ["Journal of Aerosol Medicine and Pulmonary Drug Delivery"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/full-xml/10.1089/jamp.2014.1176", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.liebertpub.com/doi/pdf/10.1089/jamp.2014.1176", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 9]], "date-time": "2018-08-09T16:08:44Z", "timestamp": 1533830924000}, "score": 14.002264, "issued": {"date-parts": [[2015, 10]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2015, 10]]}, "issue": "5"}, "alternative-id": ["10.1089/jamp.2014.1176"], "URL": "http://dx.doi.org/10.1089/jamp.2014.1176", "ISSN": ["1941-2711", "1941-2703"], "issn-type": [{"value": "1941-2711", "type": "print"}, {"value": "1941-2703", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T14:46:18Z", "timestamp": 1576853178486}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "21", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2012, 11, 1]]}, "DOI": "10.1158/1078-0432.ccr-12-1803", "type": "journal-article", "created": {"date-parts": [[2012, 9, 8]], "date-time": "2012-09-08T05:09:13Z", "timestamp": 1347080953000}, "page": "5845-5849", "source": "Crossref", "is-referenced-by-count": 106, "title": ["U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma"], "prefix": "10.1158", "volume": "18", "author": [{"given": "R. A.", "family": "de Claro", "sequence": "first", "affiliation": []}, {"given": "K.", "family": "McGinn", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Kwitkowski", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Bullock", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Khandelwal", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Habtemariam", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Ouyang", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Saber", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Koti", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Rothmann", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Shapiro", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Borrego", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Clouse", "sequence": "additional", "affiliation": []}, {"given": "X. H.", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Brown", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Akinsanya", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Kane", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Kaminskas", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Farrell", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Pazdur", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2012, 9, 7]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-12-1803", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T03:27:55Z", "timestamp": 1482463675000}, "score": 13.788131, "issued": {"date-parts": [[2012, 9, 7]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 11, 6]]}, "published-print": {"date-parts": [[2012, 11, 1]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-12-1803", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}